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Abstract	
Jaclyn Ann Witko	
EFFECTS OF BIOENGINEERING SCAFFOLDS RELEASING NEUROTROPHINS AND 
BODY WEIGHT SUPPORTED TREADMILL TRAINING 
2015 - 2016 
Tom Merrill, Ph.D. 
Master of Science in Mechanical Engineering 
 
Changes in monosynaptic reflex, often used to study spasticity, has been tested 
through the H-reflex in spinal cord injury (SCI) patients after rehabilitation training, such 
as body weight support treadmill training or cycling. The combinational effects of 
rehabilitation training and a bioengineered scaffold on spasticity in SCI animal model 
have not been studied. We used a clinically relevant animal model of spinal cord 
moderate contusion at T9/T10 with BWSTT and the bioengineered scaffold PNIPAAm-
g-PEG loaded with the growth factors BDNF/NT-3 to measure the efficiency of the 
combinational bioengineered approach to treat spasticity. Five animal groups were 
included in the study: sham, injury, SCI + BWSTT, SCI + PNIPAAm-g-PEG with 
BDNF/NT-3 (Transplant), and SCI + BWSTT/PNIPAAm-g-PEG with BDNF/NT-3 
(combinational). Results indicate that there was an increase in the over ground BBB test 
scores from the BWSTT, and combinational groups from weeks 6-8, but not in the 
transplant only or injury groups when compared to the sham. There was also a decrease 
in habituation of the H-reflex and restoration of rate depression properties in both the 
BWSTT and combinational groups.  
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Chapter 1 
Introduction 
Background 
Spinal cord injury (SCI) affects an estimated 40 cases per million population in the 
United States with about 12,500 new cases reported each year, according to the National 
Spinal Cord Injury Statistical Center. Studies have shown that vehicle crashes are the 
leading cause of injury, and spinal cord injuries are the second leading cause of paralysis 
among Americans (Christopher and Dana Reeve Foundation, April 2009). There is no 
known cure for spinal cord injuries and available treatments just help minimize pain and 
discomfort, thereby slowing the progression of secondary damage. One such secondary 
problem that results after SCI is spasticity, which is reported in 65 -78% of patients 
(Adams et al., 2005). Treatment options are currently available to decrease spasticity and 
the associated pain and discomfort. One of those treatments is an activity based 
rehabilitation therapy, which includes body weight support treadmill training. Body 
weight support treadmill training after an incomplete spinal cord injury can help retrain 
the complex circuitry and connections within the spinal cord (SC), resulting in functional 
improvement. Since greater sparing within the SC after injury can result in higher 
functional improvement (Nógrádi et al., 2000-), neuroprotection and regeneration 
transplantation treatment strategies, combined with training, should improve the 
outcomes after body weight support treadmill training. Transplantation of cells that have 
been genetically engineered to deliver neurotrophins, such as brain derived nerve growth 
factor, (BDNF) or neurotrophin-3 (NT-3), because they have neuroprotective and 
neuroregenerative properties. BDNF has been studied and shown to stimulate growth of 
2	
	
vestibulospinal fibers (Boyce et al., 2014), which are fibers found within the 
vertibulospinal tract that runs along each side of the central nervous system (Pease, 
2006). BDNF has also been found to cause increased excitability of motor neuron in an 
injured spinal cord, but has no effect on the strength of synaptic projections to motor 
neurons, unlike NT-3. NT-3 will enhance the strength of synaptic projection to the motor 
neurons and will increase corticospinal fiber growth (Boyce et al., 2014). These fibers are 
found in the corticospinal tract, which consists of four columns of motor fibers that run 
along either side of the spinal cord (Pease, 2006). The BDNF and NT-3 will work 
together after injury to protect and minimize the secondary damage of the pathways, 
while promoting growth of new pathways based on their properties of repairing the spinal 
cord (Boyce et al., 2014). These neurotrophins have the potential to help reduce spasticity 
because it is caused by the damage that occurs to the nerve pathways (Reese et al., 2006). 
Previous studies conducted by Skinner et al., 1996 and Phadke et al., 2006, among others 
have shown that if there are more spared pathways within the injury site that are 
preserved, the less severe spasticity the patient will experience. 
  Many different cell types pose a problem when tested in animal models in regards to 
rejection, regulation of release among others (Assuncáo-Silva et al., 2014). To overcome 
these problems, our study uses the bioengineered scaffold poly N-(isopropylacrylamide) 
– poly (ethylene glycol) (PNIPAAm-PEG) loaded with neurotrophins as a transplant 
because it has shown to be highly biocompatible, and when functionalized to secrete a 
neutrtrophic factor, it can promote regeneration and functional recovery in a surgically 
induced spinal cord injury animal model (Comolli et al., 2009).   
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Problem statement. To study changes in monosynaptic, also known as H-Reflex, 
reflex pathway after combinational treatment using bioengineered scaffold (PNIPAAM-
PEG) secreting neurotrophins (BDNF+NT3) and rehabilitation training using body 
weight support treadmill training (BWSTT) in a clinically relevant contusion spinal cord 
injury (SPI) animal model. 
Hypothesis. Neurotrophins secreting scaffold will protect and minimize the 
secondary damage that the descending pathways undergo, while promoting growth of 
new pathways that together will help restore the H-reflex response after body weight 
support treadmill training (BWSTT). 
Organization of thesis. This first chapter is an outline of why our research is relevant 
to spinal cord injuries. It states the problem statement along with the hypothesis 
proposed. Chapter 2 discusses the spinal cord in detail, including injury types, anatomy, 
and current treatments for spinal cord injuries. Chapter 3 discusses the reflexes and 
spasticity that occur in the spinal cord, how they are studied, and how they relate to the 
current problem statement and hypothesis. Chapter 4 presents therapeutic approaches to 
treat spasticity in spinal cord injuries, including rehabilitation, transplant, and 
combinational biomaterials. Chapter 5 is the manuscript, and provides a draft for future 
publication. Lastly, Chapter 6 is conclusions and future work, and discusses where the 
research will lead in the future and more studies that are needed in order to enhance 
spinal cord injury research.  
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Chapter 2 
The Spinal Cord 
Anatomy 
Vertebral column (spine). The vertebral column, commonly known as the spine, 
consists of vertebrae and intervertebral (IV) discs. The vertebrae of the spine are broken 
down into five different sections: cervical, thoracic, lumbar, sacrum, and coccyx. They 
can be seen in Figure 1 from both the anterior and right lateral views. The five sections of 
the spine will be discussed in more detail in the upcoming sections (2.1.1.1). The spine 
runs from the base of the skull to the bottom of the coccyx, and typically measures 72 -75 
cm long (Figure 1D). The intervertebral discs account for approximately one quarter of 
the spine. There are five different joints of the vertebral column (Moore, 1980). The 
vertebral column is capable of producing six different motions: flexion, extension, lateral 
flexion and extension, and rotation. These movements can be seen in Figure 2.  
 There are a total of four curvatures of the adult spine: thoracic, sacral kyphosis, 
cervical, and lumbar lordosis. Figure 3 illustrates the development of the curvatures in the 
spine throughout infancy, childhood and adulthood. Figure 4 shows the surface anatomy 
of the four curvatures. The thoracic and sacral kyphosis are concaved anteriorly and are 
considered primary curvatures that develop during the fetal period. The other two 
curvatures, cervical and lumbar lordosis, are secondary curvatures that are concave 
posteriorly. These secondary curvatures result from the extension from the flexed fetal 
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position. The curvatures of the vertebral column also provide additional flexibility 
(shock-absorbing resilience) in combination with the intervertebral discs (Moore, 1980). 
 
 
            
(Moore, 1980) 
Figure 1. Vertebral column and its five regions (Moore, 1980). 
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(Moore, 1980) 
Figure 2. Movements of vertebral column (Moore, 1980). 
 
 
 
 
(Moore, 1980) 
Figure 3. Curvatures of vertebral column (Moore, 1980). 
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 (Moore, 1980) 
Figure 4. Surface anatomy of curvatures of vertebral column (Moore, 1980). 
 
 
Vertebrae. Vertebrae are one of the components that make up the vertebral 
column. There are a total of 33 vertebrae in five different regions. The cervical region has 
7, 12 of which are in thoracic, 5 in lumbar, 5 in sacral and 4 in coccygeal. The vertebrae 
in the cervical, thoracic and lumbar regions are considered superior vertebrae. These 
regions are where the most amount of movement is seen, and the sacral and coccygeal 
regions are considered inferior vertebrae. The vertebrae in the sacral and coccygeal 
regions will eventually fuse together, about age 30, to form the sacrum and coccyx. As 
shown in Figure 1A, there is an increase in size of the vertebrae as one moves down the 
vertebral column to the sacrum where they become smaller. Figure 5 illustrates a typical 
structure of the vertebrae, including of a vertebral body, a vertebral arch and seven 
processes (Moore, 1980). 
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(Moore, 1980) 
Figure 5. Typical vertebra, represented by the 2nd lumbar vertebra (Moore, 1980). 
 
Intervertebral (IV) discs. IV discs can be found in between the vertebral bodies 
(Figure 6). The discs made up between 20 -25% of the entire vertebral column. The main 
roles of intervertebral discs are to allow movement between adjacent vertebrae and 
provide an extra layer of “cushion” to absorb the shock. The IV disc has two parts: the 
anulus fibrosus and nucleus pulposus. The nucleus pulposus is the inner gelatinous 
central mass and is surrounded by the annulus fibrosus. The anulus fibrosus is a ring 
made up of concentric layers of fibrocartilage, which protects the nucleus pulposus, 
located at the core of the disc. The nucleus pulposus is a very important part of the 
vertebrae because it is responsible for the flexibility and resilience of the IV disc and the 
vertebral column, due to its semifluid nature. The core of the disc is constantly deforming 
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due to vertical forces. When the vertebral column is compressed it becomes broader, and 
when it is stretched it is thinner. The structure and function of the IV discs can be seen in 
Figure 7 (Moore, 1980).  
 
 
(Moore, 1980) 
Figure 6. Lateral view of the lumbar vertebrae (Moore, 1980). 
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(Moore, 1980) 
Figure 7. Structure and function of intervertebral (IV) discs (Moore, 1980). 
 
Nervous system. The nervous system can be broken down into two separate parts 
the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS 
consists of the brain and the spinal cord, and the PNS contains nerve fibers and cell 
bodies outside the central nervous system. Figure 9 shows the basic organization of the 
nervous system. Both the CNS and PNS will be discussed in more detail in the next two 
sections (Moore, 1980).  
 Nervous tissue contains two main cell types - neurons and neuroglia. Neurons are 
known for their rapid communication and are classified into two main groups - multipolar 
motor neurons and pseudounipolar sensory neuron. Neurons are all comprised of a cell 
body and an axon. The cell body has extensions named dendrites, which carry impulses 
to the cell body, and the axon carries the impulse away from the cell body. Some axons 
of the neurons will be encapsulated by a myelin sheath, which consists of layers of lipids 
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and proteins. This myelin sheath increases the velocity of the impulse conduction. These 
neurons will communicate with each other through synapses. Synapses are simply just 
the points of contact between neurons. Figure 8 show a pictorial representation of a 
multipolar motor neurons synapsing. During a synapse, communication occurs through 
neurotransmitters that have been secreted by a neuron. The communication is received by 
another neuron. This process keeps continuing until communication is finished and a new 
synapse occurs. Neuroglia, which are more commonly known as glial cells, function to 
support the neurons. They are five times more abundant than neurons are. There are 
different neuroglia within the CNS and PNS. In the CNS, they include oligodendroglia, 
astrocytes, ependymal cells, and microglia. In the PNS they can include satellite cells and 
Schwann cells (Moore, 1980). 
 
 
12	
	
 
Figure 8. Multiple motor neurons synapsing (Moore, 1980). 
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(Moore, 1980) 
Figure 9. Basic organization of the spinal cord (Moore, 1980).  
 
 
Central nervous system (CNS). The CNS consists of the brain and spinal cord, 
and allows incoming and outgoing neural signals to coordinate to produce movements, as 
well as to carry out higher mental functions. The brain and the spinal cord are composed 
of gray and white matter. The gray matter, at the center of the spinal cord, resembles the 
shape of the letter H, and is composed of nerve cell bodies (Moore, 1980). The 
arrangement of the gray matter is organized into nine distinct laminae, labeled I through 
IX (Figure 10); (Nógrádi et al., 2000-). The white matter surrounds the gray matter and is 
an interconnecting fiber tract system. The CNS is protected by meninges and the 
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cerebrospinal fluid (CSF). The meninges are a three-layered membrane that is made up of 
the pia mater, arachnoid mater and dura mater. The pia mater is the inner most layer and 
is directly covers the spinal cord. The arachnoid mater is the middle layer, and the 
outermost layer is the dura mater. The dura mater is very tough, unlike the pia mater 
which is very delicate. The cerebrospinal fluid is found between the pia mater and the 
arachnoid mater. The meninges are shown in Figure 11 (Moore, 1980). 
 
(Anatomy) 
Figure 10. Spinal cord nuclei and laminae (Anatomy). 
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(Moore, 1980) 
Figure 11. Spinal cord and spinal meninges (Moore, 1980). 
 
 
Peripheral nervous system (PNS). The PNS consists of the nerve fibers and cell 
bodies that lie outside the brain and spinal cord. In Figure 9, the different part of the PNS 
is marked by two red asterisks. This system can either conduct impulses to or away from 
the brain and spinal cord. PNS is an organization of nerves (Moore, 1980). 
 A nerve is composed of nerve fibers which have three parts - an axon, its 
neurolemma, and endoneurial connective tissue. A neurolemma is another term for 
Schwann cell. The Schwann cells have two forms they can take, which then gives rise to 
two different nerve fibers, myelinated and unmyelinated. The difference between the two 
nerve fibers is their ability to produce myelin. As stated previously, myelin increases the 
speed at which the impulses are conducted. Myelinated nerve fibers have Schwann cells 
that are specific to a particular axon and an unmyelinated nerve fiber has Schwann cells 
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that are not specific to just one axon. An illustration of myelinated and unmyelinated 
nerve fibers is shown in Figure 13. Nerves are simply a bundle of nerve fibers that are 
surrounded by a connective tissue covering loaded with blood vessels that nourish the 
entire nerve. The connective tissue covering is divided into three parts - endoneurium, 
perineurium and epineurium. These three parts together allow the nerve to be fairly 
strong and resilient. Figure 13 shows the endoneurium as the innermost layer surrounding 
the nerve fiber and the epineurium being the outermost layer (Moore, 1980). 
 The nerves of the peripheral nervous system are broken down into two main 
sections -  cranial nerves and spinal nerves. Spinal nerves exit the vertebral column and 
are known as rootlets, which then form two nerve roots. The two nerve roots are anterior 
(ventral) and posterior (dorsal). The anterior (ventral) nerve root has motor (efferent) 
fibers that convey neural impulses from the brain and spinal cord to effector organs, 
which include muscles and glands. The posterior (dorsal) nerve root has sensory 
(afferent) fibers that convey neural impulses to the brain and spinal cord from sensory 
organs and sensory receptors. Figure 14 shows how the nerve roots form from the rootlets 
and stem from either side of the grey matter (Moore, 1980).  
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(Moore, 1980). 
Figure 12. Myelinated and unmyelinated nerve fibers (Moore, 1980). 
 
 
(Moore, 1980) 
Figure 13. Arrangement and ensheathment of myelinated nerve fibers (Moore, 1980). 
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(Moore, 1980) 
Figure 14. Spinal cord gray matter, spinal roots, and spinal nerves (Moore, 1980).  
 
Spinal Cord Injury 
Epidemiology. SCI is reported in 25.5 cases per million or about 40 million 
people worldwide. The average age of these people is 31.7 years, mainly ranging from 20 
to 35 (Assuncão-Silva et al., 2014; Nas et al., 2015). Spinal cord injuries are more 
commonly seen in young men (Assuncão-Silva et al., 2014), but 1% of the reported cases 
are children (Nas et al., 2015). In children 60-80% of injuries occur in the cervical region, 
and the remaining 20-45% are split evenly between the thoracic and lumbar regions (Nas 
et al., 2015). The number one cause of spinal cord injuries is due to motor vehicle 
accidents (24%), followed by accident working (28%) and sporting/recreation (16%) 
(Christopher and Dana Reeve Foundation, April 2009). Another major number for spinal 
cord injuries are that they are the second leading cause of paralysis (23%) after stroke 
(29%). The exact breakdown of the numbers per cause of spinal cord injuries and cause 
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of paralysis can be seen in the two pie charts below (Figures 15 and 16) (Christopher and 
Dana Reeve Foundation, April 2009). 
 Spasticity is reported in over a half a million people in the United States and over 
12 million people all over the world (Voerman et al., 2005). Literature also report that it 
affects 42.7%, 65-78%, 70% and 80% of people living with spinal cord injuries 
(Kakebeeke et al., 2005; Adams et al., 2005; Hagen, 2015; Elbasiouny et al., 2015; 
respectively). Even after 10 years post injury, 35% of patients still reported having 
spasticity as a side effect (Kakebeeke et al., 2005).  
 
                                                       
(Christopher and Dana Reeve Foundation, April 2009) 
Figure 15. Causes of Spinal Cord Injuries. 
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(Christopher and Dana Reeve Foundation, April 2009) 
Figure 16. Causes of Paralysis.  
 
 
Injury types. Spinal cord injuries are classified into two main types, complete 
and incomplete. A complete injury is considered to be traumatic and an incomplete injury 
is non-traumatic (Sabapathy et al., 2015). When a person has a complete spinal cord 
injury they have a complete loss of motor and sensory functions from the point of injury 
down to the distal point of the spinal cord. On the other hand, an incomplete spinal cord 
injury has partial motor and sensory functions below the level of neurological disrupt and 
in the lower sacral segments (Kirshblum et al., 2011; Nas et al., 2015). Typically, spinal 
cord injuries are caused by flexion, compression, hyperextension or flexion-rotation 
mechanisms. This initial response of these mechanisms is known as the primary damage. 
The secondary damage is the response from the body because of the primary damage. 
Secondary damage is seen in the form of hemorrhaging, inflammation and the release of 
different chemicals from the body (Nas et al., 2015). 
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American spinal injury association (ASIA). Spinal cord injury patients are 
classified using the Spinal Injury Association (ASIA) scale (Kirshblum et al., 2011; Nas 
et al., 2015). This scale was last revised in 2011 (Nas et al., 2015). The scale ranges from 
A-E, where A is the most severe injury and E is completely normal. The table below 
outlines each level of the scale and what classifies a patient in the different levels 
(Kirshblum et al., 2011; Nas et al., 2015).  
 
 
(Nas et al., 2015)  
Figure 17. American Spinal Injury Association scale for spinal cord injury 
 
Animal Models of Spinal Cord Injuries 
 Different animal models are used depending on the research that is being 
performed. There are four main types of models that are used for spinal cord injury 
research, which include hemi-section, compression, contusion, and transection. Table 1 
below shows a summary of the current spinal cord injury animal models that are used to 
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mimic human spinal cord injuries. To simulate an incomplete spinal cord injury, the 
hemi-section, compression and contusion models are typically used, and for a complete 
injury a transection model is used. For our study, we performed a moderate contusion 
injury at T9/T10 using a weight drop system. In a hemi-section model, a portion of the 
spinal cord is removed at the desired level, simulating an incomplete injury where the 
transection model removes the entire cross-section of the spinal cord at a particular level. 
In the compression and contusion models, a dorsal laminectomy is performed first to 
expose the spinal cord. In the compression models, calibrated forceps are used to 
compress the exposed spinal cord, and in the contusion model a weight drop device is 
dropped on the particular level of injury desired. The weight drop system can account for 
a mild, moderate, or severe injury depending on the height it is dropped from. Figure 18 
shows a contusion and compression injury being performed (Blight, 2000). 
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Table 1 
Summary of the current SCI animal models that are used in research to mimic the 
clinical human SCI.  
 
(Kundi et al., 2013) 
 Note: These animal models are used to asses, behavior, histology and genetic alterations 
following SCI, but more importantly to assess neural and molecular outcomes. These 
models are more frequently developed on Rat and Mice and less frequently on larger 
animals such as Cats and Dogs (Kundi et al., 2013). 
 
24	
	
(Blight, 2000) 
Figure 18. Contusion and compression injuries of the spinal cord usually involve 
exposing the spinal cord with a dorsal laminectomy, typically in the thoracic region but 
sometimes in cervical or lumbar spinal cord. The spinal cord is then compressed, either 
from the dorsal surface (A, B) or from the sides (C,D). In contusion injury, a cylindrical 
weight (A) is dropped from a given height into the spinal cord or a similar cylinder may 
be depressed with a motor, controlled by a computer. In static compression injuries a 
heavier weight is simply placed onto the spinal cord. In both cases, the dorsal surface of 
the spinal cord is displaced downward. This produces distributed hemorrhage in the 
spinal cord at the site of compression. The compression also produces a displacement of 
the central contents of the cord in cranial and caudal directions (B), particularly in a 
narrow region above and around the central canal. Lateral compression injury can be 
produced with calibrated forceps that are inserted on either side of the spinal cord (C) and 
closes together(D) inducing a similar central hemorrhagic necrosis and displacement of 
the centrally located, damage tissue in cranial and caudal directions (Blight, 2000).  
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Pathophysiology of SCI 
 In an event of a trauma to the spinal cord, there is primary and secondary damage. 
When the initial injury occurs, the body triggers a series of cellular and biochemical 
events that allow a lesion or injury site to form in the spinal cord. Some of the immediate 
changes that occurs after this primary damage are disrupted blood vessels and extensive 
apoptosis (Assuncão-Silva et al., 2014). After the primary damage is done secondary 
damage starts to set in. The secondary damage changes depending on the severity of the 
primary damage, and can be divided into three different sections - acute phase, subacute 
phase, and chronic phase. Each of these phases has a timeline associated with them- 
acute: 2 hours to 2 days, subacute: days to weeks, and chronic: months to years 
(Sabaphathy et al., 2015). Initially, in the secondary damage in the acute phase, an 
inflammatory environment occurs because of cellular and molecular interaction of 
macrophages, neutrophils and leukocytes (Assuncão-Silva et al., 2014; Sabaphathy et al., 
2015). The purpose of these interactions is to phagocyte cell debris and to prevent further 
tissue damage. Then, in the subacute phase, a fluid-filled cyst forms at the injury site, 
where a glial scar forms around the cyst. The glial scar is mainly made up of reactive 
astrocytes and is supposed to stabilize and protect the damaged spinal cord. In reality, the 
glial scar and its cells release inhibitory proteins such as chondroitin sulfate 
proteoglycans (GSPGs) and axonal growth inhibitors. These proteins and inhibitors do 
not allow axonal regeneration and remyelination along the damaged spinal cord 
(Assuncão-Silva et al., 2014). Figure 19 below is a pictorial representation of the 
mechanism of a spinal cord injury. At the injury or lesion site, the neural tracks have been 
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severed, the formation of the glial scar appeared and lymphocytes, monocytes and 
activated astrocytes appeared to help minimize injury. These three cells tend to appear 
within the subacute phase (Sabapathy et al., 2015). 
 
(Sabapathy et al., 2015) 
Figure 19. Mechanism of spinal cord injury (Sabapathy et al., 2015).  
 
Spasticity after SCI. The cause of spasticity is still unknown, but from the 
previous epidemiology section we know it greatly affects spinal cord injury patients. 
Spasticity is one of the symptoms of the upper motor neuron syndrome and is seen in the 
form of exaggeration of the stretch reflex, secondary to hyper-excitability of spinal 
reflexes (Adams et al., 2005; Elbasiouny et al., 2010). It can also be seen in forms other 
than reflexes, such as hyperreflexia, clonus, clasp-knife responses, ling-lasting cutaneous 
reflexes, and muscle spasms. Spasticity develops gradually, starting in the subacute 
phase. After injury, the spinal cord is in spinal shock, which is seen by the loss of tendon 
reflexes below the injury site. Muscle paralysis and flaccid muscle tone occurs. Over the 
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span of the subacute and chronic phases, new reflexes start to appear, like the tendon 
reflex among others. This causes the threshold of the flexor reflexes to decrease over 
time, which can cause long-lasting contractions. Later the extensor reflexes start to occur, 
which makes the flexor/extensor muscles co-contract and become more prominent.  Other 
stimulus, such as heat/cold and bladder distention can also cause these muscle spasms 
that we know as spasticity. There are many factors that affect spasticity and its severity 
(Elbasiouny et al., 2010). 
Current Treatments 
 There are three different categories of current treatments for spinal cord injuries. 
The three categories are pharmaceutical, transplant, and rehabilitation. Pharmaceutical 
treatment only includes one drug, methylprednisolone more commonly known as Medrol. 
Transplant and rehabilitation treatments are part of the therapeutic approaches to treat 
spinal cord injuries. Transplant treatments include cell-based therapies, hydrogel-based 
biomaterials and combinational biomaterials. Rehabilitation strategies include body 
weight support treadmill training, functional electrical stimulation and cycling. Next three 
sections, will elaborate more on the different categories of current treatments. In Chapter 
4, the therapeutic approaches will be discussed in further detail. 
Pharmaceutical. The only pharmaceutical that is used for treatment in spinal 
cord injuries is methylprednisolone (Medrol). There were three large randomize clinical 
trials - the National Acute Spinal Cord Injury Studies (NASCIS) I, II, III - that made this 
drug the standard for spinal cord injuries. In the first NASCIS trial, patients were 
examined for changes in their motor function and sensation. This trial produced results 
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that showed no benefit, which was thought to be due to the dosage being below the 
therapeutic threshold. The second phase of the NASICS trial used a higher dose of 
Medrol administered through a 24-hour infusion within 12 hours after injury 
(Hugenholtz, 2003). Results from this trial showed no benefit except during post hoc 
analysis. Post hoc analysis showed that within 8 hours of injury there was a small gain in 
the motor and sensory score. The NASCIS II allowed Medrol to become the standard 
care for acute spinal cord injuries. NASCIS III further refined the protocol that was used 
to administer Medrol (Framptom et al., 2006; Hugenholtz, 2003). Even though Medrol 
became the standard, many other clinical trials have provided conflicting evidence. Even 
though it is used today, it is still a controversial drug and its ability to help spinal cord 
injury patients is still uncertain (Hugenholtz, 2003; Hugenholtz et al., 2002).  
Transplant. Transplantation therapies in animal models of SCI are currently 
being investigated extensively for their translation capabilities. Some of the therapies 
being researched for transplantation are cell-bases therapies, which include stem cells, 
hydrogel-based biomaterials, which include both natural and synthetic hydrogels, and the 
combination of both cell-based therapies and hydrogels. When looking at cell-based 
treatments they must be able to possess the ability to 1) minimize the secondary injury, 2) 
replace and minimize the survival of damaged cells and 3) alter the local environment to 
be more conductive for regeneration (Sabapathy et al., 2015; Tam et al., 2014). In 
general, stem cells have been tested from different origins to see if they are capable of 
nerve regeneration and possess the ability to restore the complex circuitry of the spinal 
cord when transplanted into the injury site. More on the specific outcomes from the 
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different types of stem cells can be found in Chapter 4. Hydrogel-based biomaterials have 
become popular in spinal cord repair because hydrogels have great physical properties 
and chemical composition. The physical properties allow the hydrogel to have the ability 
to mimic the environment of the central nervous system and its chemical composition is 
easily integrated into the extracellular matrix. Hydrogels, because they are a biomaterial, 
still have to overcome biocompatibility, mechanical and physicochemical properties, 
porosity and permeability, and biodegradability. The hydrogel-based biomaterials are 
extensively outlined in Chapter 4 under the hydrogel-based biomaterials section 
(Assuncão-Silva et al., 2014).  
Rehabilitation. Rehabilitation is currently the most widely used treatment for 
spinal cord injuries. This therapeutic rehabilitation includes body weight support 
treadmill training, functional electrical stimulation, and cycling. These approaches have 
shown to have the capability to decrease symptoms of spinal cord injury, especially 
spasticity. More on these three rehabilitation strategies can be found in Chapter 4. 
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Chapter 3 
Reflexes and Spasticity 
Overview 
The Hoffmann (H) - reflex is a monosynaptic reflex (Lee et al., 2005; Gozariu et 
al., 1998) elicited by the synaptic activation of motor neurons by muscle afferents 
following stimulation of muscle nerves (Reese et al., 2006; Skinner et al., 1996) that was 
first studied in the 20th century by Paul Hoffman on the triceps surae. In 1973, Hoffman 
published “Methodology of the Hoffman Reflex in Man” which became the guidelines of 
parameters for achieving the H-reflex (Tucker et al., 2005; Gozariu et al., 1998).    
In a non-injured patient, the expected outcome of the H-reflex is decrease in the 
amplitude with increasing stimulus frequency of 1Hz or higher (Reese et al., 2006) while 
the M-wave amplitude remains constant (Figure 20). The M- and H-wave are obtained 
through an electrical stimulation of a peripheral nerve that innervates the muscle where 
the H-reflex is recorded. When a single stimulus is initiated, it generates a short latency 
M-wave and long latency H-wave. The M-wave appears because of the direct stimulation 
of the motor axons innervating the muscle, and the H-wave is the measure of the alpha 
motor neurons activated by Ia afferents (Lee et al., 2005). After injury, the H-wave 
amplitude become less sensitive to stimulation, which results in a higher H/M ratio, and 
the ratio becomes higher at the baseline stimulus frequency (Lee et al., 2005). The M- 
and H-wave will be discussed in more detail in the Section 3.3. 
31	
	
Spasticity is a common side effect of spinal cord injuries and can be seen when 
testing the H-reflex. Spasticity is measured through the habituation that occurs during 
electrical stimulation. When there is no habituation that occurs at higher frequencies it is 
known that spasticity occurred because of the spinal cord injury. This habituation can be 
seen by observing the M- and H-wave during testing (Yates et al., 2008). Spasticity can 
cause loss of mobility and produce pain from muscle spasms (Mukherjee et al., 2010). 
From Chapter 2 we know that spasticity occurs after injury to the spinal cord and is also 
the most observed phenomena after injury. There is no one exact cause of spasticity, it 
occurs from a combination of effects. Spasticity effects over a half a million spinal cord 
injury patients in the United States and over 12 million worldwide (Voerman et al., 
2005). More on spasticity and how it relates to the H-reflex and the effects of different 
rehabilitation strategies will be discussed later in this chapter in Section 3.4.  
 
(Lee et al., 2005) 
Figure 20.  Response of H-reflex for a non-injured animal with increasing stimulus 
frequency. The H-wave decrease with increasing frequency while the M-wave remains 
constant (Lee et al., 2005). 
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Spasticity 
Spasticity is known to be one of the secondary symptoms that occur after spinal 
cord injuries and occurs in 65-78% (Adams et al., 2005) of patients who have had a 
chronic spinal cord injury for more than a year. It has been reported that in complete 
spinal cord injuries spasticity starts to appear 2-6 months after injury (Hagen, 2015). 
Spasticity has many definitions, but the most commonly agreed upon within the scientific 
community is that it is “a velocity-dependent increase in the tonic stretch reflexes 
(muscle tone) with exaggerated tendon jerks, resulting from the hyper-excitability of the 
stretch reflex as one component of the upper motor neuron (UMN) syndrome” (Adams et 
al., 2005; Mukherjee et al., 2010; Voerman et al., 2005). The upper motor neuron 
syndrome is the motor changes that occur in the descending motor pathways after injury 
to the spinal cord (Purves et al., 2001). In simpler terms, spasticity can affect both 
muscles and joints by having an abnormal increase in muscle tone or stiffness of the 
muscles. This can cause pain and discomfort, can interfere with movement or speech, and 
cause deformities and abnormal movements (NINDS; Voerman et al., 2005). Spasticity is 
typically caused by the damage that occurs to the nerve pathways. Some of the symptoms 
that occur with spasticity include hypertonicity (increased muscle tone), hyper-reflexia 
(Reese et al., 2006), clonus (a series of rapid muscle contractions), exaggerated deep 
tendon reflexes, muscle spasms, scissoring (involuntary crossing of the legs) and fixed 
joints (contractures). Spasticity does not just occur in spinal cord injuries, but also in 
patients with multiple sclerosis, cerebral palsy and others (NINDS). Today there is no 
current treatment that is used to cure spasticity, only treatments to reduce the symptoms. 
These treatments include medications, physical therapy and surgery. One important thing 
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to keep in mind is that no one treatment will be effective for all spinal cord injuries. The 
key is to manage each case based on the unique goal of the patient (Adams et al., 2005; 
NINDS). The next two sections will discuss spasticity and the reflexes of both humans 
and animals in different spinal cord injury models. Chapter 4 Section 4.1, will discuss 
spasticity after a therapeutic approach has been used, and its outcomes. 
Reflexes 
M-wave. One of the responses of stimulating a mixed nerve within the triceps 
surae is the M-wave. An electrical current is passed through a mixed nerve, including 
both muscle spindle afferents and motor efferents of the test muscle, initiating the 
response. The concept of mixed nerve is shown in Figure 21. When comparing the M- 
wave and the H-wave, the M-wave will appear at a higher stimulation than the H-wave 
because of the relatively thinner size of the motor nerves, compared with the muscle 
spindle Ia afferents. It also occurs at shorter latency (< 4 ms, Skinner et al., 1996; Gozariu 
et al., 1998; 5-8 ms, Tucker et al., 2005) with a maximal amplitude occurring in the range 
of 6-8 mV (Gozariu et al., 1998), because it has to travel only along the motor axons, 
approximately 5-8 milliseconds in the soleus muscle (Tucker et al., 2005). 
 The M-wave is used in studies to normalize the H-reflex results obtained. When 
normalizing the results, the H-reflex is a ratio of the maximum M-wave (M-max, H/M-
max). When the M-wave was initially studied it was believed that it was a successful and 
accurate way of measuring the total muscle activation. Further investigation showed that 
the maximum M-wave changes during experiments due to the different limb positions 
and/or during different levels of muscle contractions. This variability seen in the 
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maximum M-wave is due to the changes in the angle of the muscle fibers and electric 
stimulation. Other factors affecting the maximum M-wave are the experimental time, the 
decrease of the maximum M-wave value over time, time of day the experiment is 
conducted, and temperature of the muscle being tested. Many factors can change the 
value of the maximum M-wave, so when it is used as a normalization factor it should be 
recorded in all condition to obtain the most accurate results (Tucker et al., 2005).   
H-wave. The second response of electromyography testing is the H-reflex, which 
is a long latency (> 4 ms, Skinner et al., 1996; 11-12 ms, Gozariu et al., 1998; 3-4 ms, 
Tucker et al., 2005) compound electromyographic response with a maximal amplitude 
ranging from 1.5-2.5 mV (Gozariu et al., 1998; Yates et al., 2008). The H-reflex is a 
longer latency response because the volley begins in the afferent fibers, as shown in 
Figure 21. The response has to travel in both orthodromic and antidromic directions. 
From Figure 22 below, the orthodromic and antidromic directions are shown by the 
indicating arrows. The orthodromic direction is considered the normal direction and is 
towards the axon terminal, and the antidromic direction is away from the axon terminal 
(Tucker et al., 2005). The H-reflex measures the alpha motorneurons activated by Ia 
afferents, and is seen when the peripheral nerve is stimulated by an electrical stimulation 
(Lee et al., 2005) and evoked by muscle afferents (Reese et al., 2006; Yates et al., 2008).  
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(Tucker et al., 2005) 
Figure 21. Electrical stimulation of a mixed nerve. The mixed nerve contains Ia afferents 
and motor neurons. Action potential within the mixed nerve is then evoked by an 
electrical current depending on the thickness of the fibers in the nerve. Once the electrical 
current is large enough to elicit the action potential in the nerve fibers, the potential 
volley travels in both the orthodromic and antidromic directions to elicit the response 
(Tucker et al., 2005). 
 
 
 
        
 
(http://nervecell-assesment.weebly.com/2d-labelled-diagram.ht) 
Figure 22.  A nerve cell that shows the directions of orthodromic and antidromic 
directions.  
 
Antidromic	
Orthodromic	
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Human studies. Many studies have been conducted on human volunteers with 
different spinal cord injuries along with different environments tested. A study conducted 
by Nakazawa et al., 2006 compared the excitability stretch reflex of the soleus muscle in 
patients with clinically complete and incomplete spinal cord injury, elderly healthy 
patients, and young healthy patients. They mechanically and electrically induced stretch 
reflex, H-reflex, and M-wave responses in electromyographic activity of the right soleus 
muscle for all groups. Nakazawa et al. found that the incomplete spinal cord injury group 
had a greater absolute stretch reflex electromyographic amplitude than its relative value 
of the Mmax. The H/M ratio were comparable between the incomplete and complete 
groups, but were greater than those in the younger and elderly groups (Figure 23 and 24).  
Another study conducted by Phadke et al., 2007 compared the soleus H-reflex in 
incomplete spinal cord injury patients in two different walking environments: treadmill 
activity with body weight support and over ground walking. A total of 8 motor 
incomplete spinal cord injury patients and 8 control patients were tested for their mean 
soleus H-reflex amplitude. H/M ratio was recorded during mid-stance and mid-swing 
phases of walking. The results showed that with manual assistance and body weight 
support on the treadmill in stance phase, the H/M ratio was 33% smaller and swing phase 
was 56% smaller than over ground incomplete spinal cord injury patients. The two 
different walking environments of the control group did not change the soleus H-reflex 
modulation significantly (Figure 25). Another study looked at the effects of sinusoidal 
hip stretches on the soleus H-reflex modulation pattern in people with clinically 
incomplete spinal cord injuries (Knikou et al., 2007). Seven clinically incomplete spinal 
cord injury patients with lesions from cervical (C) 5 to thoracic (T) 11 participated in the 
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study. The study showed that when a sinusoidal stretch is imposed, it started a hip-phase 
dependent modulation of the soleus H-reflex (Figure 26). A study conducted by Phadke 
et al., 2006 looked at the different H-reflex modulation with different percentages in leg 
loading of the body weight support system in people with motor incomplete spinal cord 
injuries.  The study included 8 people with injury and 5 non-injured controls ranging 
from 42-60 of age. Phadke et al. compared 0% (100% body weight load) and 40% (60% 
body weight load) body weight support. The results showed that there was a significance 
difference in the amplitude of the soleus H-reflex in the injured and non-injured group, 
but no significance change was seen on the H/M ratios in either the injured/non-injured 
groups with 0% or 40% body weight support. This study suggests that a 40% body 
weight support load does not alter the soleus H-reflex excitability (Figure 27). The H-
reflex is a very reproducible response, but not always the most accurate. Querry et al., 
2008 wanted to develop a model that was precise and accurate during the stimulation of 
the H-reflex during specific times during the gait cycle using robotic body weight support 
treadmill training in both patients with and without spinal cord injuries. This study used 
the Lokomat system to determine the mid-stance and mid-swing points of the gait cycle. 
The H-reflex of the soleus was synchronized to the mid-stance and mid-swing, and tested 
at 1.8 and 2.5 km/h for 50 cycles. The results showed that the stimulation accuracy was 
within 0.5° of the defined hip joint position, and >85% of the 50 H-reflex cycles met the 
+/- 10% M-wave criterion that was determined during standing (Figure 28).  
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(Nakazawa et al., 2006) 
Figure 23. Summary of absolute peak-to-peak reflex electromyographic amplitude 
(SRPP), absolute Hmax value, and Mmax of each subject group. Bar height show mean 
and error bars represent the SEM. ANOVA indicated there were statistically significant 
intergroup differences in the absolute reflex electromyographic amplitude, Hmax, and 
Mmax. Abbreviations: CSCI, complete spinal cord injury; EC, elderly healthy subjects, 
ISCI, incomplete spinal cord injury; YC, young health subjects. *Significant between-
group differences revealed by Scheffé post hoc comparison (P<.05) (Nakazawa et al., 
2006). 
 
 
 
(Nakazawa et al., 2006) 
Figure 24. Summary of relative peak-to-peak stretch reflex sizes and H/M ratios for each 
subject group. Bar height show mean and error bars represent the SEM. There were 
statically significant inter-group differences in the relative peak-to-peak stretch reflex 
sizes and H/M. *Significant (P<.05) between-group difference revealed by Scheffé post 
hoc comparison (P<.05) (Nakazawa et al., 2006).  
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(Phadke et al., 2007) 
Figure 25. Persons with incomplete SCI: percentage decrease in H/M ratio while walking 
in BWSMAT environment compared with unassisted overground environment. In 
subjects 3 and 4, the H/M ratio increased in stance phase, and, in subjects 2 and 5, the 
H/M ratio did not change in the swing phase of walking in the BWSMAT environment 
(Phadke et al., 2007). 
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(Knikou et al., 2007) 
Figure 26. Characteristics of M-wave and H-reflex under control conditions and during 
sinusoidal hip stretches. For each subject identified on the abscissa, the average control 
H-reflex (A) and M-wave recorded during control conditions and following imposed 
sinusoidal hip stretches (B) are illustrated as a percentage of the maximal M-wave. 
Control H-reflexes varied from 18 to 35% of the maximal M-wave across subjects. The 
M-wave was not statistically significantly different across experimental conditions 
(P>0.05). In subject 11, the M-wave was not present at these stimulus intensities (Knikou 
et al., 2007) 
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(Phadke et al., 2006) 
Figure 27. Standing i-SCI vs. non-injured control. Comparison of H/Mmax values 
between the two BWL conditions in non-injured subjects with i-SCI. Standard error bars 
shown (Phadke et al., 2006). 
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(Querry et al., 2008) 
Figure 28. M wave to H reflex response sensitivity graphs. Data represent tibial-nerve 
stimulation ramping protocol from no M wave to maximal M wave amplitude (Mmax). 
Presented are typical responses of subjects (a) without spinal cord injury (SCI), (b) with 
American Spinal Injury Association (ASIA) A (motor complete) SCI, and (c) with ASIA 
C (motor incomplete) SCI. Solid vertical line represents measured M wave that elicited 
maximal H reflex (MHmax). Dotted vertical line represents +/-10% of MHmax percentage of 
Mmax is calculated (Querry et al., 2007). 
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Animal studies. There are several studies in animal models of spinal cord 
injuries, most in contusion or weight drop spinal cord injury model at the T8/T9 level. 
This is the most widely studied since it closely resembles the most common human spinal 
cord injuries (Magnuson et al., 1999). In all animal models, except the complete 
transection, the animals eventually regain most of their motor functions. This 
phenomenon is not seen in humans, but is actually the opposite, where even a partial 
injury to the spinal cord leads to spasticity. A negative aspect of the complete transection 
model is that the animals need much more care after injury, and very often experience 
complications. This is not to say that a complete transection model for animals is never 
studied, but it is more common to see hemi-sections, partial transections, or contusion 
injuries (Eaton, 2003). 
A study conducted by Lee et al., 2005 studied how the severity of the spinal cord 
injury affects the H-reflex at different times after injury. Four groups (Control, Mild 
Contusion, Moderate Contusion, and Transection) of adult female Sprague-Dawley rats 
were evaluated 1, 4, and 8 weeks after injury. The results showed that the H-reflex rate 
depression was seen as abnormal in all three injured groups at each time period tested. 
Week 8 is where the difference of more H-reflex rate depression was seen in the 
transected group than those of the mild contusion group. The study also showed that the 
baseline H-reflex amplitude was increased in the mild and moderate contusion group 
(Figure 29, 30, and 31). This result was also seen in Nakazawa et al., 2006 outlined in 
Section 3.3.3. A study conducted by Skinner et al., 1996 looked at the effects of exercise 
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on the H-reflex in chronically spinalized adult rats. The rats underwent a complete spinal 
cord transection at T10 level and were put on a training regimen for 3 months. The rats 
received 60 minutes of motorized bicycle exercise training a day for 5 days per week. 
Reflex testing took place after the 3 months of training occurred. The results of the H-
reflex test showed that exercise training was capable of restoring frequency-dependent 
depression of the H-reflex as in normal non-injured animals (Figure 32 and 33). A follow 
up study to Skinner et al., 1996 was the “Restoration of frequency-dependent depression 
of the H-reflex by passive exercise in spinal rats” conducted by Reese et al., 2006. This 
study aimed to investigate the time frame of passive exercise that would have similar 
outcomes as Skinner et al., 1996. Adult rats underwent a complete transection at the T10 
level followed by motorized bicycle exercise training for 1 hour per day, 5 days per week 
for either 15, 30, 45, 60, or 90 days. After training ended the H-reflex was tested. The 
results of this study showed that after 30 days of exercise, statistically significant low 
frequency-dependent depression of the H-reflex was seen. Overall there was a linear 
decrease in low frequency-dependent depression of the H-reflex with passive exercise 
(Figure 34, 35, and 36). A study by Yates et al., 2008 used a complete transection model 
to assess the hyper-reflexia, a component of spasticity after injury. The study was able to 
establish a time frame for the onset of the hyper-reflexia. They used adult rats that 
underwent complete transection at T10 level and the H-reflex was tested at 7, 14, and 30 
days’ post-transection. Results showed that the rats did in fact have spasticity in the form 
of hyper-reflexia, and it was observed to decrease when tested at 10 Hz after 14 and 30 
days. This study reports that between 7 and 14 days, the rats developed hyper-reflexia 
(Figure 37 and 38). 
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 (Lee et al., 2005) 
Figure 29. Changes in baseline H/M ratio after varying degrees of SCI. There was a 
significant increase in baseline H/M ratio at 4 weeks after a Mild and Moderate SCI. Mild 
injury continued to display an increased baseline H/M ratio at 8 weeks, although not 
significantly different from controls. Transection SCI did not differ from controls at any 
time points tested. At 8 weeks, transection SCI had significantly lower baseline H/M ratio 
compared to Mild SCI. **P<0.01, * P<0.05 compared to controls unless noted otherwise. 
Two-way ANOVA with Bonferonni post-test (Lee et al., 2005).  
 
 
                 
(Lee et al., 2005) 
Figure 30.  Overlapping representative H-reflex waveforms of uninjured control (A) and 
4-week Mild SCI (B) animals measured at 0.1, 1 and 5 Hz stimulus frequencies. The 
amplitude of the M-wave remains unchanged, while the H-wave amplitude steadily 
decreases with increasing stimulus frequency. After SCI, this rate depression property of 
the H-reflex is significantly diminished compared to uninjured controls. In addition, at 4 
weeks after SCI, the baseline amplitude (0.1 Hz) is higher than uninjured controls (Lee et 
al., 2005). 
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(Lee et al., 2005) 
Figure 31. Alteration of H-reflex rate depression over time after varying degrees of SCI. 
Higher H/M percent values on the y axis indicates less H-reflex rate depression, whereas 
lower values indicate more rate depression. H-reflex rate depression becomes more 
abnormal over time after a mild SCI, but more normal after a transection (A). At 8 weeks, 
mild injury displayed the most abnormal rate depression, while transection injury was 
closest to controls. All three injury groups had significantly less rate depression 
compared to uninjured controls at all three time points. Two-way ANOVA with 
Bonferonni post-test. #P<0.05 comparing 8 weeks to 4 weeks, @P<0.05 comparing 8 
weeks to 1 week, *P<0.05 comparing transected to mild (Lee et al., 2005). 
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(Skinner et al., 1996) 
Figure 32. Averages of 16 consecutive responses following tibial nerve stimulation 
recorded in plantar muscles in representative animals in each group. The earlier M-wave 
(~ 2 ms latency) was followed by the H-reflex (~7 ms latency). Averages of stimulation 
frequencies of 0.3 Hz and 10 Hz are superimposed for each animal. Note that the 10 Hz 
average in the control record is decreased (due to frequency-dependent depression) 
compared to the 0.3 Hz average (top left). On the other hand, the 10Hz average in the Tx 
animal did not decrease as much compared to the 0.3 Hz average (top right). The 10 Hz 
averages in both treated animals, Tx + FSCI and TX + EXER (bottom left and right) 
decreased as in the control animal. Calibration bar 2 ms for all records (Skinner et al., 
1996). 
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(Skinner et al., 1996) 
Figure 33. Graph of the mean and standard deviation of the H-reflex at 1 Hz, 5 Hz and 10 
Hz stimulation frequency as a percent of the response observed at 0.3 Hz stimulation 
frequency. Animals in the CTL group (square) showed marked decrease of the H-reflex 
amplitude as the stimulation frequency increased. After transection (Tx, diamond), there 
was decreased habituation of the H-reflex at 10 Hz (asterisk, P<0.01) compared to the 
CTL as well as the two treatment groups (Tx + RCI, circle: Tx + EXER, triangle) 
(Skinner et al., 1996). 
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(Reese et al, 2006) 
Figure 34.  Averages of H-reﬂex recordings. Evoked muscle potentials included an early 
M-wave and a later H-reﬂex following stimulation. (a) Averaged responses to stimulation 
at 0.2Hz in a control rat. (b) Averaged responses to stimulation at 10Hz in the same 
control rat. Note the decrease in amplitude (frequency-dependent depression) of the H-
reﬂex at 10Hz compared to 0.2Hz. (c) Averaged responses to stimulation at 0.2Hz in a Tx 
only 60D rat. (d) Averaged responses to stimulation at 10Hz in the same Tx only 60D rat. 
Note the greater amplitude (decrease in frequency-dependent depression) of the H-reﬂex 
at this frequency compared to 10Hz in the intact animal (b). (e) Averaged responses to 
stimulation at 0.2Hz in a Tx +Ex 60D rat. (f) Averaged responses to stimulation at 10Hz 
in the same Tx + Ex 60D rat. Note the return of frequency-dependent depression of the 
H-reﬂex after 60 days of MBET. Calibration bars vertical 0.5mV, horizontal 2ms (Reese 
et al., 2006). 
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(Reese et al., 2006) 
Figure 35. H-reﬂex amplitude at 0.2, 1, 5, and 10Hz for intact animals (control, open 
circles), and 15 (Tx + Ex 15D, ﬁlled diamonds), 30 (Tx + Ex 30D, ﬁlled circles), 45 (Tx 
+ Ex 45D, ﬁlled triangles), 60 (Tx + Ex 60D, ﬁlled plus signs) and 90 (Tx + Ex 90D, 
ﬁlled squares) days of MBET, and 90 days without MBET (Tx only 90D, open squares). 
Frequency-dependent depression of the H-reﬂex at 0.2Hz was designated 100%, and all 
statistical comparisons in this ﬁgure made against the Tx only 90D group. At 1Hz, the Tx 
only 90D group (*) diﬀered signiﬁcantly from the Tx + Ex 45D, Tx + Ex 60D, and 
control groups at the P<0.05 level (+); and from the Tx + Ex 30D group at the P<0.01 
level (++). At 5Hz, the Tx only 90D group (*) diﬀered from the Tx + Ex 45D, and Tx + 
EX 60D groups at the P<0.05 (+), and was also diﬀerent (**) from the Tx + Ex 30D and 
control group at the P<0.01 level (++). At 10Hz, the Tx only 90D group (*) diﬀered from 
the Tx + Ex 45D group at the P<0.05 level (+), and diﬀered (**) from the Tx + Ex 30D, 
Tx + Ex 60D, Tx + Ex 90D, and control groups at the P<0.01 level (++) (Resse et al., 
2006). 
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(Reese et al., 2006) 
Figure 36.  H-reﬂex amplitude at 0.2, 1, 5, and 10Hz for control (open circles), 30 days 
without MBET (Tx only 30D, ﬁlled squares), and 30 days with MBET (Tx + Ex 30D, 
ﬁlled diamonds). Frequency-dependent depression of the H-reﬂex at 0.2Hz was 
designated 100%, and all statistical comparisons in this ﬁgure made against the Tx only 
30D group. At 1Hz, the Tx only 30D group (*) diﬀered from the Tx + Ex 30D group at 
the P<0.05 level (+), but not the control group. At 5Hz, the Tx only 30D group (*) 
diﬀered from the Tx + Ex 30D group at the P<0.05 level (+) and from the CONTROL at 
the P<0.01 level (++). At 10Hz, the Tx only 30D group (*) diﬀered from the Tx + Ex 30 
group at the P<0.05 level (+), and from the control at the P0.01 level (++) (Reese et al., 
2006). 
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(Yates et al., 2008) 
Figure 37. (a) Representative H-reflex recordings of animals tested 7 days after 
transection (Tx). The H-reflex was observed 8–10ms after the stimulus. The H-reflex 
amplitudes at the different frequencies have been superimposed for comparison. The 
black line represents the H-reflex recorded at 0.2Hz. The dark gray line represents 
recording at 5Hz, and the light gray line represents recording at 10Hz. Note the decrease 
in amplitude as frequency of stimulation was increased, indicative of low frequency-
dependent depression present at 7 days post-Tx. (b) Representative H-reflex recording of 
animals tested 14 days after Tx. The H-reflex responses at the different frequencies have 
been superimposed for comparison. The black line represents H-reflex recorded at 0.2Hz. 
The dark gray line represents recording at 5Hz, and light gray line represents recording at 
10Hz. Note lack of decrement in amplitude as frequency of stimulation was increased, 
indicative of a decrease in frequency-dependent depression. The x-axis represents time in 
milliseconds, the y-axis amplitude in millivolts (Yates et al., 2008). 
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(Yates et al., 2008) 
Figure 38. H-reflex amplitude at 0.2, 1, 5 and 10Hz in intact (control, filled circles), Tx 
7D (squares), Tx 14 D (diamonds) and Tx 30D (triangles) groups. The y-axis shows 
amplitude expressed as a percent of the amplitude at 0.2Hz designated as 100 percent, 
and all statistical comparisons in this figure were made against the control group. At 5Hz, 
the Tx 14D and Tx 30D groups differed from the control group and the Tx7D (P<0.05). 
At 10Hz, the Tx 14 D group differed from the control group and Tx 7D (P<0.05), and the 
Tx 30 D group differed from the control and Tx7D group (P<0.01). *indicates P<0.05; 
**indicates P<0.01. Note the lack of habituation of the H-reflex at 10Hz in the Tx 14D 
and Tx 30D groups compared with the control group and the Tx 7D group. Tx, 
transection (Yates et al., 2008). 
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Chapter 4 
Therapeutic Approaches to Treat Spasticity in Spinal Cord Injury 
Rehabilitation 
 Body weight-support treadmill training (BWSTT). Body weight-support 
treadmill training focuses on re-training standing and walking in patients with spinal cord 
injury (Phadke et al., 2006; Querry et al., 2008) by producing a repetitive stepping pattern 
like that of normal walking (Phadke et al., 2007). There are two parts to this 
rehabilitation, namely the body weigh-support system and the treadmill. The body weigh-
support system allows a particular percentage of patient’s body weight to be supported by 
a suspended device and harness taking pressure and weight off the legs. This system is 
suspended over a treadmill so the patient can walk with either manual or robotic help 
(Phadke et al., 2006). The robotic system is very beneficial for researchers and clinicians 
because it allows them to be able to monitor joint position, torques, and the overall 
performance of the patient with better accuracy and precision. This robotic training also 
gives a better monitored environment allowing the patients’ monosynaptic reflex to be 
measured through H-reflex during standing and stepping, allowing assessment of the 
improvement throughout the body weigh-support treadmill training process. (Querry et 
al., 2008). After training, spasticity should normalize, which is evident by the observed 
changes in the H-reflex, such as the H-wave becoming more sensitive to a reapplied 
electrical stimulation (Knikou et al., 2007).  Another benefit of body weight-support 
treadmill training that are typically not discussed are the physiological and psychological 
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benefits for patients. They can improve the overall health of the patient, not just the 
spinal cord injury (Hicks et al., 2008). 
Functional electrical stimulation (FES). Functional electrical stimulation (FES) 
has always been used in orthopedic and neurological rehabilitation, and is now being 
used for spinal cord injuries. This rehabilitation can have a therapeutic or functional 
effect. This section will focus on the therapeutic effects only. The ultimate goal of using 
FES is to reduce muscle spasms and the effects of spasticity by obtaining responses in the 
nervous system. During FES, a low level of electrical current is applied to a paralyzed 
nerve or muscle via, an electrode controlling the neural activation, in hopes to restore or 
achieve function. FES is typically combined with some form of physical activity such as 
cycling. Cycling will be discussed more in the next section (Martin et al., 2012; Peckham, 
1989). Studies have shown that functional electrical stimulation by itself, used with 
incomplete and complete spinal cord injury patients, causes an increase in stepping 
response and an activation of the central pattern generator mechanism. Patients when 
regularly treated also show improvement in motor and sensory scores and decrease in 
spasticity (Martin et al., 2012). 
Cycling. Cycling movements is another rehabilitation strategy that is used in 
spinal cord injuries. It is a passive exercise that helps to maintain full range of motion of 
the joints that are immobilized (Kakebeeke et al., 2005; Rayegani et al., 2011). Studies 
have shown that it can reduce spasticity in patients as well as cardiac output and stroke 
volume, and muscle atrophy (Rayegani et al., 2011). Cycling is sometimes preferred over 
body weight-support treadmill training if researchers are studying the H-reflex, because it 
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can allow them to see all the muscles being activated. Also changing the load can 
increase or decrease the levels of muscle activation (Boorman et al., 1992). One study 
conducted by Reese et al., 2006 used motorized bicycle exercise training to measure 
hyper-reflexia by restoring the frequency-dependent depression of the H-reflex. They 
used a complete spinal cord transection model with rats that underwent training for 1 
hour per day, 5 days per week for 3 months and were then tested at 15, 30, 45, 60, and 90 
days after training began. The results showed that after 30 days of exercise there was a 
statistically significant low frequency-dependent depression of the H-reflex. 
Transplant 
 Cell-based therapies. Stem-cell therapies have many of the qualities necessary to 
promote regeneration in spinal cord injuries, and are widely studied because of their 
differentiation potential (Assuncão-Silva et al., 2014). For these therapies to be successful 
in spinal cord regeneration they need to 1) minimize the secondary injury, 2) replace and 
minimize the survival of damaged cells and 3) alter the local environment to be more 
conducive for regeneration (Sabapathy et al., 2015; Tam et al., 2014). Combining stem-
cell with growth factors allows a strategy to control cell fate after transplantation (Tam et 
al., 2014). Some transplantation strategies have been tested more than others and 
investigated through clinical trials. This research, though, has not yet shown a clear 
convincing pattern in the results of significantly promoting regeneration in spinal cord 
injuries. Additional studies are needed to safely and efficiently use stem-cell therapies as 
a possible treatment for spinal cord injury (Assuncão-Silva et al., 2014). Stem-cells that 
are being studied include: embryonic, induced pluripotent, neural, mesenchymal, and 
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glial cells, which will be discussed in the upcoming sections (Assuncão-Silva et al., 2014; 
Tam et al., 2014).    
Embryonic stem cells (ESC). Embryonic stem cells (ESC)are pluripotent cells 
(Tam et al., 2014) that can differentiate into more than 200 different fetal cell lineages 
(Tewarie et al., 2008; Assuncão-Silva et al., 2014). These cells are present within the 
inner cell mass of the blastocyst, which is formed very early on in development (Tewarie 
et al., 2008). Many studies have been conducted to look at ESC and their ability to 
specifically differentiate into neural and glial cells. Neural and glial cells and their roles 
in spinal cord injury repair are discussed more in later Sections 4.2.4 and 4.2.6 
(Assuncão-Silva et al., 2014). Through the different studies using a spinal cord injury 
model it has been shown that ESC offer good long-term treatments because of their 
ability to survive in the injured spinal cord (Tewarie et al., 2008). A study conducted by 
Keirstead et al., 2005 used human ESC that were differentiated into oligodendrocyte 
progenitor cells (a subtype of glial cells) and were implanted into the injury site of the 
spinal cord either 7 days or 10 months after injury. This study showed that the rats with 
the transplant of cells after 7 days had recovery of motor function whereas the rats with 
transplant after 10 months did not. The overall outcome of this study claims that 
embryonic stem cell have therapeutic potential with a time frame limitation in which 
these cells can be therapeutic.  
Induced pluripotent stem cells (iPS cells or iPSCs). Induced pluripotent stem 
cells (iPSCs) are another type of stem cell that can be obtained directly from adult tissues 
and used for autologous transplantation. They are obtained by reprogramming 
58	
	
differentiated adult cells through the introduction of 4 transcription factors (OCT3/4, 
SOX2, KLF4, and MYC) that revert them to an embryonic stage (Assuncão-Silva et al., 
2014; Tam et al., 2014; Tewarie et al., 2008). They are similar to embryonic stem cells in 
their characteristics, such as pluripotency, self-renewal capacity, and gene expression 
(Assuncão-Silva et al., 2014). Researchers are looking into using iPSCs instead of 
embryonic stem cells because of the ethical issues that are associated with them later 
(Tewarie et al., 2008). iPSCs are useful because they run no risk of immune rejection of 
transplants. A potential problem is the formation of tumors. Tumor formation in induced 
pluripotent has been widely studied and is now being studied for the use of cellular 
system for spinal cord injury treatment. One study implanted human induced pluripotent 
stem cells derived neurospheres (hiPSC-NSs) into non-obese diabetic-severe combined 
immunodeficient (NOD-SCID) spinal cord injury model mice. There was an 
improvement of the functional activity of the mice, because there was evidence of 
formation of synapses between the cells and the neurons, increased in the expression of 
neurotrophic factors, angiogenesis, axonal regrowth and myelination of the injury site. 
This evidence was prominent because the cells differentiated into neurons, astrocytes, 
and oligodendrocytes. There was also no tumor formation reported. Another study that 
was conducted in 2012 used pre-evaluated neural stem/progenitor cells (NS/PCs) clones 
that were derived from both mice and human induced pluripotent stem cells. The model 
used a contusion spinal cord injury in nonhuman primates. Similar results of cell survival 
and differentiated into neurons, astrocytes, and oligodendrocytes, were seen without 
evidence of tumor formation. The results were also promising with axonal 
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sparing/regrowth and angiogenesis at the injury site and functional recovery of the animal 
(Assuncão-Silva et al., 2014).  
Neural/progenitor stem cells (NSPCs). Neural/progenitor stem cells (NSPCs) are 
used in spinal cord injuries because they are multipluripotent and found in the central 
nervous system, and offer neuroprotection and axon regeneration properties. These stem 
cell are unique because they have been found to have the ability to differentiate into the 
three main neural cell linkages: neurons, oligodendrocytes, and astrocytes (Assuncão-
Silva et al., 2014; Tam et al., 2014; Tewarie et al., 2008). NSPCs have been tested in 
many spinal cord injury models including contusion, traumatic, and complete injury with 
promising results (Assuncão-Silva et al., 2014). In contused adult rat model, the NSPCs 
were found to produce neurons that travel along the spinal cord. This also resulted in 
improvement in the patient’s overall function (Kakulas, 2004). The study using a cervical 
contusion-induced spinal cord injury showed that human NSPCs can survive and 
eventually differentiate into the four neural cell linkages. It was reported that there was a 
decrease in the injury site, and also an increase in motor activity of the animals (Iwanami 
et al., 2005). In a transection spinal cord injury model of rats, fetal neural stem cells were 
implanted. After two months, the cells were found to form ectopic colonies. These 
colonies were seen dispersing into the CNS where they were dividing into several neural-
cell lineage types (Lu et al., 2012). They secreted a variety of molecules that had the 
potential to protect cells from death, and also secrete neurotrophic factors. Both in in 
vitro and in vivo tests, the secretion of growth factors that the NSPCs give off was found 
to promote growth of the host axons, which are sensitive to neurotrophic factors. More 
60	
	
testing has shown that combinational treatment of these NSPCs, and the growth factor 
neurotrophin-3 (NT-3), offer extremely promising results by expanding the growth and 
penetration of host axons along the injury site (Assuncão-Silva et al., 2014; Tewarie et 
al., 2008). More on combinational treatment will be discussed in Section 4.4. These 
NSPCs were studied in 2011 in a phase I/II clinical trial by a company in Switzerland. 
This company specifically used purified fetal human neural stem cells (HuCNS-SC) for 
the treatment of chronic thoracic spinal cord injury in both complete and incomplete 
patients. The clinical trial used a total of 12 patients, 7 of them having complete injuries 
and 5 incomplete. Results were only reported for 8 of the 12 patients. 4 of the complete 
injury patients showed a significant improvement in sensory function. Two patients with 
incomplete injuries gained sensory perception, and the third remained altered (Assuncão-
Silva et al., 2014).  
Mesenchymal stromal stem cells (MSCs). Mesenchymal stromal stem cells 
(MSCs) were first thought to be only present within bone marrow, but are also found in 
non-marrow tissue. These cells are multipotent and can differentiate into osteoblasts, 
chondrocytes and adipocytes in vitro (Assuncão-Silva et al., 2014; Tam et al., 2014). The 
advantage of using (MSCs) is that they are more available because they can be found in 
multiple tissues. There are no ethical or political issues during the isolation process 
(Assuncão-Silva et al., 2014).  
 The use of MSCs and different strategies have been studied, but there is not yet a 
clear census of the outcomes. Some of the outcomes reported are that in vitro bone 
marrow mesenchymal stromal stem cells (BM-MSCs) differentiate into neuron-like cells 
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and glial cells, and in vivo they migrate across the blood-brain barrier, repopulate the 
CNS, and differentiate into microglia-like cells. Researchers are interested in their trophic 
activity rather than strictly using them as a therapeutic agent. MSCs secrete a set of 
bioactive molecules and/or microvesicles, which is called secretome.  This secretome is 
thought to have neuroprotection and axon regeneration properties after spinal cord injury 
by suppressing local immune response, enhancing angiogenesis and inhibiting scarring 
and cell apoptosis (Assuncão-Silva et al., 2014). This process can be seen in Figure 39.  
 When specifically looking at spinal cord injury treatment, MSCs are used in two 
different ways: transplantation of the cells into the injury site and administration of 
secretome. Many studies have been conducted for transplantation of the MSCs using 
either intravenous or subcutaneous injections, as well as direct injection into the injury 
site. All of these studies using these different techniques showed functional recovery after 
spinal cord injury. Studies using administration of the secretome also showed promising 
results. (Assuncão-Silva et al., 2014).   
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 (Assuncão-
Silva et al., 2014) 
Figure 39. Application of mesenchymal stromal stem cells (MSCs) as a treatment for 
spinal cord injury. The MSCs secretome is believe to be a key player on the promotion of 
neuroregeneration and neuroprotection, as well as the modulation of the inflammatory 
response (Assuncão-Silva et al., 2014). 
 
 
Glial cells.  
Olfactory ensheathing cells (OECs). Olfactory ensheathing cells (OECs) are used 
in spinal cord injury repair because studies have shown functional recovery after 
transplantation. These cells are a specialized glial cell found in the olfactory system. The 
cells have been shown to promote axonal regeneration of olfactory nerve fibers into the 
olfactory bulb of the CNS, serving as a pathway for regeneration of the olfactory receptor 
neurons, by creating cellular channels that the axon can grow through (Assuncão-Silva et 
al., 2014; Radtke et al., 2008). They can prevent axons from recognizing growth 
inhibitory molecules, and this allows them to elongate into otherwise inhibitory terrain 
(Tewarie et al., 2008). Additionally, they can produce different neurotrophic factors 
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(Radthke et al., 2008), including nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neuregulins, and glial cell line-derived neurotrophic factor (GDNF) 
(Assuncão-Silva et al., 2014). Olfactory ensheathing cells have been tested in phase I/II 
clinical trials in complete thoracic injuries and severe chronic spinal cord injuries. In the 
complete thoracic injuries clinical trial, the safety and feasibility was first tested. The 
results showed that, after one and three years, there were no safety issues observed with 
the procedure, no cord cyst or tumor formation, no neuropathic pain and deterioration in 
neurological status, and finally no functional changes in the patients. In the phase I/II 
pilot clinical study with severe chronic spinal cord injury patients, olfactory mucus 
autographs were transplanted. Results showed motor improvements in 11 of the 20, with 
some complications in 5 of the patients (Assuncão-Silva et al., 2014).   
Schwann cells (SCs). Schwann cells (SCs) are another form of glial cells just like 
the OECs, but they are primarily found in the PNS. These cells have become of more 
interest in spinal cord injuries because they may allow damaged axons in the central 
nervous system to regrow and remyelinate, just as it does in the PNS. Many studies have 
been conducted, but their results are contradictory. Some report that in the presence of 
astrocytes, the Schwann cells are not sustainable, but then some reports show evidence in 
their ability to promote regeneration. Some of the studies that support the evidence that 
they can promote regeneration involve transplantation of autologous SCs into thoracic 
injuries of cat spinal cord, human SCs grafted in a transected nude rat spinal cord, and 
adults SCs in a moderately contused adult rat thoracic spinal cord. These SCs, just like 
the OECs, have the unique property to overexpress NGF or BDNF. These genetically 
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modified SCs have shown a tremendous increase in axonal growth and remyelination 
after transplantation into adult rats with spinal cord injuries. Since there have been 
promising outcomes in the animal SCI models, it has been translated over to clinical 
trials. One study used autologous transplantation of SCs into patients with chronic spinal 
cord injuries. They injected the cells directly into the lesion by intramedullary delivery. 
The results showed no harmful effects after one and two years, and no real benefits were 
observed in the patients. This study ultimately showed that there is no danger associated 
with the procedure. In 2013, the Miami Project to Cure Paralysis performed the first ever 
FDA approved SC transplantation into a patient with complete thoracic spinal cord 
injury. This was a phase I clinical trial to test the safety and the ability to transplant the 
patient’s own SCs. Four weeks after injury the cells were transplanted into the patient and 
no adverse signs were reported. The next part of the phase I clinical trial enrolled 8 more 
patients with acute thoracic spinal cord injuries and is currently ongoing (Assuncão-Silva 
et al., 2014). 
Hydrogel-based biomaterials. Hydrogel-based biomaterials have gained interest 
in spinal cord research. While using hydrogels for drug and cell delivery to the central 
nervous system, which is composed of the brain, spinal cord, and retina, there are many 
properties that need to be taken into consideration. Some of which include 
physicochemical and mechanical properties, biodegradability/bio absorbability, and 
biocompatibility. Some of these properties can be seen in Table 4.1 below. Since 
hydrogels possess these properties, they are an excellent candidate for neural tissue 
repair.  In the upcoming sections, synthetic and natural-based hydrogels are outlined, and 
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the role they play within spinal cord injury research is discussed (Assuncão-Silva et al., 
2014; Tam et al., 2014).  
(Tam et al., 2014) 
Figure 40. Hydrogel properties considered relevant for drug and cell delivery to the 
central nervous system (Tam et al., 2014). 
 
 
Synthetic hydrogels. Synthetic hydrogels have one main advantage of being able 
to be manipulated to have specific mechanical and physicochemical properties 
(Assuncão-Silva et al., 2014; Kim et al., 2014). It is also easy to blend two or more of 
these different synthetic polymers to create something unique with the specific properties 
needed. A set back that comes with these synthetic hydrogels is the fact that they are 
capable of producing an immune response within the body, and therefore have limitations 
with the FDA approval (Kim et al., 2014). 
Poly (lactic acid) (PLA). Poly-lactic acid (PLA) is a biodegradable aliphatic 
polyester, and is a member of the α-hydroxy acid class of compounds. Its chemical 
66	
	
structure is shown in Figure 40 (Assuncão-Silva et al., 2014; Kim et al., 2014). A 
disadvantage of PLA is that it is structurally unstable, fragmenting and collapsing on 
itself. Even with the instability it has shown that it supports axon extension and vascular 
growth into the graft. PLA scaffolds are used as only a temporary extracellular matrix. 
Implanting PLA alone, either in a hydrogel, macroporous sponge, micro- or nano-fiber or 
multi-walled conduit forms showed promising results. The next logical step would to be 
to combine the poly-lactic acid with a therapeutic drug to improve the outcome. Through 
the research, there has not been a clear result for successful axonal regeneration in animal 
spinal cord injuries. Much more research is needed to optimize the results (Kim et al., 
2014). 
 
(Mahapatro et al., 2011) 
Figure 41. Chemical Structure of poly (lactic acid) (PLA). 
 
Poly (lactic-co-glycolic acid) (PLGA). Poly-lactic-co-glycolic acid (PLGA) has 
been approved by the FDA for the repair of human peripheral nerves. It is now being 
researched for use in the CNS related injuries including spinal cord injuries. PLGA is a 
polymer made up of two different monomers; glycolic acid (Figure 42, X) and lactic acid 
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(Figure 42, Y). The degradation and mechanical properties of this synthetic hydrogel can 
be varied depending on its particular application, by varying the ratio of the monomer 
units and their stereochemistry (either D- or L-form), along with varying the molecular 
weight distribution of the monomer chains (Assuncão-Silva et al., 2014; Kim et al., 
2014). 
 PLGA has evolved throughout the years in relation to how it’s being used. It 
initially started off as a delivery agent of neurotrophic factors in tissue engineering 
(Assuncão-Silva et al., 2014) and has evolved into a microsphere for drug delivery. 
Today it is a nanoparticle that encapsulates different therapeutic drugs. Some of the more 
recent studies of PLGA involve the delivery of certain stem cells, such as MSCs, neural 
stem cells and SCS. In a rat hemisection injury model, a PLGA scaffold containing neural 
stem cells showed a major improvement in spinal cord function, and in a canine model it 
showed that there is a possibility for spinal cord regeneration. In a rat complete 
transection model, PLGA hydrogels, loaded with human MSCS, showed improvement in 
both behavior analysis and motor-evoked potentials (MEP’s). PLGA definitely has the 
potential in spinal cord injury repair, but needs to be studied more extensively (Kim et al., 
2014).  
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(Mahapatro et al., 2011) 
Figure 42. Chemical structure of poly (lactic-co-glycolic acid) (PLGA). X and Y 
represent the number of lactic acid and glycolic acid respectively (Mahapatro et al., 
2011).  
 
 
Methacrylate-based hydrogels.  
Poly [N-2-(hydroxypropyl) methacrylamine] (PHPMA). Poly [N-2-
(hydroxypropyl) methacrylamide] (PHPMA) is a hydrophilic co-polymer, that has 
neuroinductive and neuroconductive effects, and the chemical structure is shown in 
Figure 43. There currently is a PHPMA hydrogel, that was developed for spinal cord 
injury, commercialized today. The hydrogel is known as NeuroGel™, and it contains 
PHPMA with an Arg-Gly-Asp (RGD) modification. (Kim et al., 2014). Throughout the 
years researching PHPMA, the results were extremely promising. In a transected rat 
spinal cord model, the hydrogel was found to successfully bridge the gap at the site of 
transection (Assuncão-Silva et al., 2014). The hydrogel also helped with cell growth, 
angiogenesis and axonal growth, all within the microstructure of the spinal cord. This 
study also concluded that the growth of reparative tissue containing glial cells, blood 
vessels, axons, dendrites, and extra cellular matrix molecular (Assuncaão-Silva et al., 
2014; Kim et al., 2014) was present and favored. Other studies have also reported 
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reduction of necrosis, motor benefits and improved locomotor BBB scores (Assuncão-
Silva et al., 2014).  
 
(Ulbrich et al., 2010) 
Figure 43. Chemical Structure of poly [N-2-(hydroxypropyl) methacrylamide (PHPMA). 
 
Poly 2-hydroxyethyl methacrylate (PHEMA)/poly 2-hydroxyethyl methacrylate-
co-methyl methacrylate (PHEMA-MMA). Poly 2-hydroxyethyl methacrylate (PHEMA) 
hydrogel is made up of hydrophilic co-polymer that are cross-linked networks. The 
chemical structure is shown in Figure 44. This hydrogel is able to absorb water and retain 
it without dissolving, which provides a 3D substrate for cell attachment and growth. It is 
a known fact that most synthetic hydrogels are not biodegradable but this PHEMA 
hydrogel is ideal in tissue engineering because it has ideal physical properties and is very 
biocompatible (Assuncão-Silva et al., 2014; Kim et al., 2014). An interesting property 
that PHEMA has is that when it is being produced into a hydrogel, it can be made to have 
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similar mechanical properties of the spinal cord. The more similar they are, the least 
likely issues are to arise after implantation (Kim et al., 2014).  
  Kim et al., 2014 studied both PHEMA and its co-polymer PHEMA-MMA and 
reported that they promoted axon regeneration. The hydrogels were then modified to 
obtain better mechanical strength and function by adding coiled channels (Assuncão-
Silva et al., 2014; Kim et al., 2014). The surface of the hydrogels were either positively 
charged or negatively charged. Results showed that the positively modified hydrogels 
were better at promoting axon growth and regeneration than both the unmodified or 
negatively charged hydrogels. More recently, studies have been done to access the 
capability of using PHEMA and its co-polymer PHEMA-MMA to deliver therapeutic 
cells. One study used PHEMA with MSCs in a hemisected rat spinal cord model. The 
results showed that it promoted regeneration of the axons (Kim et al., 20114).  
 
(Morita, 2014) 
Figure 44. Chemical structure of poly (2-hydroxyethyl methacrylate) (PHEMA). 
 
Poly (ethylene glycol) (PEG). Polyethylene glycol (PEG) shown in Figure 45 is a 
synthetic hydrogel used in many aspects of spinal cord injuries. It is a water-soluble 
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nontoxic polyether that is known to have protective effects on the spinal cord by resisting 
protein adsorption and cell adhesion (Assuncão-Silva et al., 2014; Kim et al., 2014). 
These protective effects allow a PEG hydrogel to be injected into the body without the 
body producing an immune response. As stated before, PEG has a natural effect on the 
spinal cord, so researchers started to develop different cross-links using PEG. Different 
cross-links were created to increase/decrease degradation rate and increase cell adhesion 
(Assuncão-Silva et al., 2014). 
 PEG has a wide range of uses as a biomaterial. Studies have shown promising 
outcomes. An in vivo model using just a PEG solution injection into a spinal cord injury 
showed potential for accelerating and enhancing the membrane resealing process, and 
also restoring neuronal membrane integrity (Assuncão-Silva et al., 2014). Another study 
reported that cross-linked PEG with poly (N-isopropylacrylaminde) (PNIPAAAm) in to a 
spinal cord injury allowed axonal growth and successful cell transplants or BDNF release 
(Kim et al., 2014). Another study looked at the effects of using PEG hydrogel loaded 
with NT-3, which was implanted into a rat model of spinal cord injury. Results from this 
study showed that there was an improvement in the rat’s locomotor behavior and more 
axonal growth (Assuncão-Silva et al., 2014). In our study, we used a combination of the 
cross-linked PEG and PNIPAAAm loaded with BDNF and NT-3. In Chapter 5, the 
results of the study will be discussed.  
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(Barron, 2015) 
Figure 45. Chemical structure of poly (ethylene glycol) (PEG).  
 
Natural-based hydrogels. Natural-based hydrogels are commonly made up of 
natural polymers (e.g. Proteins) and/or molecules that are naturally found within the 
human body, because it is easier for integration and interaction with the tissue already 
present. Most of the natural-based hydrogels are substances that are found within the 
bodies extra cellular matrix or have existing properties of the cells. This gives the 
hydrogel a seamless integration into the injury site. Another unique trait is that these 
hydrogels have similar properties of the soft tissue that they are replacing within the 
spinal cord. One problem, though, of the natural-based hydrogels is the chance for 
immune reactions from the existing tissue because they are derived from natural sources 
(Assuncão-Silva et al., 2014; Kim et al., 2014).  
Agrose. Agrose is a linear polysaccharide of D-galactose and 3,6-anhydro-L-
galactopyranoe (Figure 46) that is derived from the cell walls of red algae making it 
biocompatible. It is used in three different varieties as a delivery vehicle for drug or 
macromolecules in animal models of spinal cord injuries; encapsulation, tubular, and 
hydrogel. This section will focus on the hydrogel. One of the main applications of agrose 
hydrogel is local delivery of BNDF because of the porous nature of the structure and 
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mechanical properties similar to that of the tissue. One trait that intrigues researchers to 
study agrose hydrogel as a tissue engineering approach for spinal cord repair is their 
ability to polymerize in situ thereby adapting to the different shapes of lesion because of 
their ability to fill different types of neurological defects.  
 Previous studies involving agrose hydrogels have already proven the potential 
uses for them because of their ability to support neurite extension in vivo. In a contusion 
and dorsal-over hemisection rat model of spinal cord injuries, the agrose hydrogels 
loaded with methylprednisolone nanoparticles were able to provide a local and gradual 
release of the drug. The results showed that the lesion volume was reduced, as well as a 
decreased in the expression of proinflammatory proteins when compared to systematic 
methylprednisolone delivery. Another study used the agrose hydrogel delivery system to 
deliver lipid microtubes that have been loaded with different drugs. The main drug used 
was thermostabilized chondroitinase ABC (chABC) (Assuncão-Silva et al., 2014; Kim et 
al., 2014). Over time, the chondroitinase ABC was released and showed an improvement 
in reducing the deposition of chondroitian sulfate proteoglycans (CSPGs) (CSPGs are a 
major class of axonal growth inhibitors) and eliminating the use pumps or catheters 
(Assuncão-Silva et al., 2014). It is also shown that if these agrose hydrogels containing 
chondroitinase were combined with NT-3 that there was locomotor recovery with axonal 
regeneration in injured rats (Kim et al., 2014).  
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 (National; CID=11966311). 
Figure 46. Chemical structure of Agarose. 
 
Alginate. Alginate is also a linear polysaccharide like agarose that is derived from 
the cell walls of brown algae and is composed of repeating structures of (1-4) linked β-D-
mannuronate acid (Figure 47, M) and α-L-guluronate acid (Figure 47, G). This 
polysaccharide has both biocompatibility and bioresorption properties, which allows it to 
be used in cell encapsulation, cell transplantation, and tissue engineering (Assuncão-Silva 
et al., 2014; Kim et al., 2014). In a transection spinal cord injury model of young rats, the 
alginate provided a pathway for the severed axons and also decreased astrocytosis 
between the alginate and the spinal cord (Kim et al., 2014). In an acute cervical spinal 
cord of adult rats, the alginate was found to promote axon regeneration across the 
scaffold (Assuncão-Silva et al., 2014). One issue that occurs with using this natural 
alginate is that it has a high degradation rate and cytotoxicity, and mammals do not 
possess the correct enzymes to degrade high molecular polymers of alginate. The 
addition of poly (lactic-co-glycolic acid) (PLGA) microspheres allows for a controlled 
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environment for enzymatic degradation (Assuncão-Silva et al., 2014; Kim et al., 2014). 
Another point to be aware of when using natural alginate is that they include toxic 
impurities and have to go through an extensive ultra-purification process before it is 
transplanted within the body safely (Kim et al., 2014).  
 
 
Figure 47. Chemical structure of alginate. 
 
Collagen. Collagen is a protein found within the extra cellular matrix of mammals 
and accounts for about 25-30% of the total proteins. There are a total of 29 different 
collagen types. Collagen is used as a natural based hydrogel because of its binding sites 
that are used for cell adhesion, cell migration, proliferation, differentiation. They are also 
biocompatible, biodegradable, and noncytotoxic (Assuncão-Silva et al., 2014; Kim et al., 
2014). When looking at the mechanical properties of collagen, it has a very high 
mechanical strength that is closely related to that of soft tissue (Kim et al., 2014). One 
aspect of collagen that makes it easier to produce a hydrogel is that the gel formation can 
be produced by just changing the pH balance. Collagen is not only used in spinal cord 
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injuries, but in burns, wound dressings and nerve regeneration. There have been many 
studies conducted on different models using neurotrophic factors, among others, to 
deliver therapeutic cells. A recent study conducted in 2014, used collagen hydrogels as a 
vessel for the delivery of NT-3 in spinal cord injury rats. The results showed an aligned 
axonal regeneration, and an increase in the number of regenerating axons were observed 
in the vessels delivering the neurotrophin-3 (Assuncão-Silva et al., 2014). 
 
(Shoulders et al., 2009) 
Figure 48. Collagen triple helix structure. 
 
Fibrin. Fibrin is a fibrous protein that is involved during the clotting process of 
our body and acts as a binding agent between the molecules. It is produced during the 
coagulation process where fibrinogen has been severed by thrombin producing fibrin 
monomers. The process of fibrinogen and fibrin formation during the coagulation process 
is shown and explained in Figure 49 (Assuncão-Silva et al., 2014; Kim et al., 2014). 
When fibrin is used in hydrogels for tissue engineering, it poses some advantages and 
disadvantages. One of the advantages is that the gelation of the hydrogel can be 
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controlled through different concentrations of thrombin during the coagulation process, 
offering researchers the possibility to maintain a liquid hydrogel during injection and 
once in the body a solid hydrogel. But on the other hand, these fibrin hydrogels 
originating from mammals degrade rapidly, posing a problem with contamination from 
blood-derived pathogens or prion proteins, and some studies report that inhibits neurite 
outgrowth and activates scar formation (Assuncão-Silva et al., 2014).  Despite these 
disadvantages, fibrin hydrogels have still been tested and showed promising results. 
Studies have been conducted on subacute, hemisected and severe, among others, using 
different growth factors, and stem cells, and all have shown some type of improvement, 
whether it be an increased neural fiber sprouting or some degree of axonal growth. Fibrin 
hydrogels have a very promising future in spinal cord injuries because they have the 
greatest potential for a minimally invasive approach for patients (Assuncão-Silva et al., 
2014; Kim et al., 2014). 
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(Undas et al., 2011) 
Figure 49. Fibrinogen and fibrin formation. Fibrinogen is composed of 2Aα, 2Bβ, and 
2γ-chains, which are arranged in a dimer of bilateral symmetry. The central E-region 
contains the N-termini of all 6 chains. The D-region, which is connected with the E-
region by a coiled coil segment, is composed of the β- and γ-chain C-termini. The α-chain 
C-termini fold back on the coiled coil and interact with the E-region. Fibrin formation 
involves cleavage of FpA (fibrinopeptide, orange) by thrombin (fibron I), which 
polymerizes into protofibrils. Subsequently, FpB (fibrinopeptide, green) is cleaved by 
thrombin (fibrin II). FpB cleavage is associated with release of the C-terminal α-domains, 
which interact for lateral aggregation (Undas et al., 2011).  
 
Chitosan. Chitosan is also a linear polysaccharide that is composed of randomly 
distributed β-(1-4) linked D-glucosamine (deacetylated unit) and N-acetyl-D-
glucosamine (acetylated unit) (Figure 50). Chitosan can be made from chitin found in 
crustacean shells. Crustacean shells are the second most abundant biopolymer, with 
cellulose being the first (Assuncão-Silva et al., 2014). Since the origin of where chitosan 
is derived can change, the physicochemical properties change and are directly related 
from the source because of affect they have on the size and shape of the pores (Kim et al., 
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2014). Chitosan hydrogels can be created by different bonding of the molecules, and can 
even form a hydrogel by itself through hydrogen bonds, hydrophobic interactions, and 
chitosan crystallites (Assuncão-Silva et al., 2014; Kim et al., 2014). When looking at 
chitosan by itself, without any additives, it shows neuroprotective effect and helps aid 
physiological recovery in traumatic spinal cord injuries. Research shows when the 
chitosan hydrogel loaded with neural stem cells was transplanted in complete spinal cord 
transection and subacute spinal cord injury model of rats that there was an increase 
survival rates and regeneration of the spinal cord. These results only showed functional 
recovery when treated with growth factors and soluble Nogo-66 receptor in transection 
model and dibutyryl cyclic-AMP in the subacute model.  But in acute model of rats, 
results showed enhancement of both functional recovery and nerve regeneration with 
chitosan hydrogels loaded with bone marrow stromal cells (Kim et al., 2014).  
 
(Lee et al., 2012) 
Figure 50. Chemical structure of chitosan. 
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Hyaluronic acid. Hyaluronic acidic is a natural polysaccharide consisting of 
glucuronic acid and N-acetylglucosamine. Figure 51 below represents the chemical 
structure. It is used as a hydrogel because of its ability to be completely biodegradable, 
non-cytotoxic, and biocompatible, but it has weak mechanical properties and high 
degradation rate.  To increase the mechanical properties other polymers are incorporated 
with the hyaluronic acid. Also, the surface of hyaluronic acid does not allow the cell to 
bind in an efficient manner, but this problem is overcome by modifying the acid to allow 
the cells to bind more easily. Researchers are trying to design the perfect hyaluronic acid 
hydrogel with different modification, because it is known that hyaluronic acid can help to 
reduce scar formation at the injury site. Some of the combinations that have been studied 
are high molecular weight hyaluronic acid, one modified with nogo-66 receptor antibody, 
and addition of brain derived neurotrophic factor (BDNF). The results showed that for the 
high molecular weight and modified with nogo-66, it reduced astrocytes activation and 
decreased chondroitin sulfate proteoglycans (CSPG) deposition in vivo. The hydrogel 
containing brain derived neurotrophic factor prevented an inflammatory reaction and 
increased motor functions in a rat spinal cord injury model (Kim et al., 2014).  
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(National; CID=3084050) 
Figure 51. Chemical Structure of Hyaluronic Acid. 
 
Self-assembling peptides. Another different approach from hydrogels and cell 
therapies in spinal cord injury research is the use of self-assembling peptides, which are 
nanomaterials that have the capability to form a scaffold by themselves when present 
within a solution that has similar properties to that of the extra cellular matrix (Kim et al., 
2014). Depending on the contents of the solution through the self-assembling peptides, 
there can be changes to obtain a specific required response (Assuncão-Silva et al., 2014). 
The self-assembling peptides are made up of short repeating units of amino acids that 
produce nanofibrous scaffolds in response to thermal or pH. These peptides are used 
because they are reabsorbable, allow biofunctionalizations, and can easily be made into a 
liquid injectable that will form a scaffold when injected into the tissue. Studies have 
shown that different self-assembling peptides have the ability to improve function and 
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histological recovery in an acute rat model and promotes neurological recovery (Kim et 
al., 2014). 
Combinational Biomaterials 
 Combinational biomaterials are becoming the norm in spinal cord regeneration. 
Biomaterials alone can help to improve injury, as mentioned in previous sections in this 
chapter, with some limitations. These limitations as thought to be overcome by 
combining biomaterials with cell based therapies. Some of these combinations were 
mentioned briefly in the individual sections of both the cell based therapies and hydrogel 
based therapies and, will be discussed in a bit more detail in this section.  
 The first combination that will be discussed is using neural stem cells (NSC) with 
a poly-lactic-co-glycolic acid (PLGA). This scaffold was injected into spinal cord injury 
rats and results showed cell viability for a greater length of time and improved functional 
recovery of the rats according to Xiong et al., 2009 and Teng et al., 2002. Another study 
conducted by Rauch et al., 2009, used a hemisection spinal cord injury model to deliver 
both neural stem cells and endothelial cells. Researchers used two biomaterials 
containing poly-lactic-co-glycolic acid as the outer section and poly (ethylene glycol) / 
poly-L-lysine (PEG/PLL) as the inner section of this co-delivery system. The endothelial 
cells were present within this scaffold to promote vascularization, which in theory helped 
increase neural stem cells survival. Results of this study showed that there was an 
increase in the blood vessels at the injury site, but the survival of the neural stem cells did 
not increase. 
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 The next combination using MSCS with a biomaterial poly (D, L-lactide-co-
glycolide) / small intestinal submucosa (PLGA/SIS) in a complete transection spinal cord 
injury showed that it started nerve regeneration. Most successful studies using MSCs use 
macro porous hydrogels based on derivatives of with 2-hydroxyethly methacrylate 
(HEMA), 2-hydroxypropyl methacrylamide (HPMA), or co-polymers of PHEMA. The 
results of these studies are very promising with the hydrogel promoting cell growth, axon 
growth in the proximal and distal stumps and reabsorption of the hydrogel by 
macrophages within the body and its replacement with newly formed tissue. This tissue 
was also found to contain connective tissue elements, blood vessels, astrocytic processes, 
and neurofilaments (Assuncão-Silva et al., 2014). 
The use of natural hydrogels to deliver mesenchymal stem cells have also been 
studied, but not in as much detail as synthetic hydrogels. These studies include the use of 
agarose, alginate, and fibrin among others. The results from these studies are not as 
promising as the use of synthetic hydrogels, but are still being studied to improve the 
results (Assuncão-Silva et al., 2014). Using combinational biomaterials for spinal cord 
injuries holds much promise for the future, and future studies are needed to find cure for 
SCI.  
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Table 2 
Therapeutic potential of combinational approaches based on cell therapy and 
biomaterials for spinal cord injury treatment (Assuncão-Silva et al., 2014). 
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Using Bioengineered Scaffold Loaded with Neurotrophins to Enhance Functional 
Recovery after Locomotor Training in Spinal Cord Injury Animals 
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Abstract 
Changes in monosynaptic reflex, often used to study spasticity, has been tested 
through the H-reflex in spinal cord injury (SCI) patients after rehabilitation training, such 
as body weight support treadmill training or cycling. The combinational effects of 
rehabilitation training and a bioengineered scaffold on spasticity in SCI animal model 
have not been studied. We used a clinically relevant animal model of spinal cord 
moderate contusion at T9/T10 with body weight support treadmill training and the 
bioengineered scaffold poly (N-isopropylacrylamide-) poly (ethylene glycol) 
(PNIPAAm-g-PEG) loaded with the growth factors BDNF/NT-3 to measure the 
efficiency of the combinational bioengineered approach to treat spasticity. Five animal 
groups were included in the study: sham, injury, SCI + body weight support treadmill 
training (BWSTT), SCI + PNIPAAm-g-PEG with BDNF/NT-3 (Transplant), and SCI + 
combination of body weight support treadmill training with PNIPAAm-g-PEG with 
BDNF/NT-3 (combinational). Results indicate that there was an increase in the 
overground BBB test scores from the BWSTT, and combinational groups from weeks 6-
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8, but not in the transplant only or injury groups when compared to the sham. There was 
also a decrease in habituation of the H-reflex and restoration of rate depression properties 
in both the BWSTT and combinational groups. This allows new pathways to be opened 
to explore unique tissue-engineering approaches with promising clinical application for 
patients with incomplete SCI’s.  
Introduction 
 Spinal cord injury is a condition that affects about 40 million people worldwide 
(Assuncão-Silva et al., 2014) with more than 11,000 new cases reported in the United 
States and Canada alone (Lam et al., 2007). The number one leading cause of spinal cord 
injuries are accidents while working (28%), followed by motor vehicle accidents (24%) 
and sporting/recreation (16%). Spinal cord injuries are also the second leading cause of 
paralysis (23%) (Christopher and Dana Reeve Foundation, April 2009). Due to the 
disruption within the motor and sensory systems after SCI, paralysis, spasticity, 
anesthesia, and hyper-reflexia below the lesion site is observed. Spasticity resulting from 
SCI due to changes in the motorneuron properties is observed in 65-78% (Adams et al., 
2005) of SCI patents and is measured by the Hoffman or H-Reflex/monosynaptic reflex 
(Reese et al., 2006). The H-reflex is elicited by the synaptic activation of motorneurons 
by muscle afferents, following electrical stimulation of muscle nerves (Reese et al., 2006; 
Skinner et al., 1996). In normal patients, the H-wave amplitude decreases with increasing 
electrical stimulus (Reese et al., 2006), and after injury, becomes less sensitive which 
produces a higher H/M ratio (Lee et al., 2005).  
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 Current treatments for spasticity after SCI include activity based rehabilitation 
therapies, such as body weight support treadmill training (BWSTT). The overall goal of 
this activity based rehabilitation therapy is to “target activation of the neuromuscular 
system below the level of the lesion, with the goal of retaining the nervous system to 
recover specific motor tasks” (Jones et al., 2012). This therapy focuses mainly on 
incomplete injuries because there is some preservation of the pathways below the level of 
injury, where as in a complete injury, there are no descending/spared pathways. Complete 
spinal cord injuries have never shown any recovery in over-ground walking, whereas 
body weight supported treadmill training has proven to enhance locomotor recover in 
incomplete injury patients (Lam et al., 2007). Since it has been proven that body weight 
supported treadmill training increased locomotor outcomes of incomplete spinal cord 
injuries, it shows that the level of recovery depends on the amount of spared descending 
pathways. To enhance the functional recovery while using this therapy, transplantation 
treatment strategies are added. These transplantation strategies have to 1) minimize the 
secondary injury 2) replace and minimize the survival of damaged cells and 3) alter the 
local environment to be more conductive for regeneration (Jones et al., 2012).  To 
achieve the goals of transplantation strategies, neurotrophins growth factors, called 
neurotrophins, are used. Neurotrophins, such as BDNF and NT3, are neuroprotective and 
neuroregenerative agents that minimize tissue loss, promote regeneration and sprouting 
of injured axons, and help bridge the gap of injury (Boyce et al., 2014). Clinical transition 
of cell transplantation treatments secreting these neurotrophins still poses several 
problems including rejection, and release of the cells and the approaches used (Assuncão-
Silva et al., 2014). To overcome these problems, we propose using the bioengineered 
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scaffold poly (N-isopropylacrylamide)-poly (ethylene glycol) (PNIPAAM-g-PEG) loaded 
with neurotrophins. In past studies, PNIPAAm-g-PEG has shown to be highly 
biocompatible, and biodegradable, and has the ability to release a drug over a long 
duration of time. It can also be functionalized to secrete neurotrophins (Alexander et al., 
2014; Comolli et al., 2009). In summary, this study aims to investigate changes in H 
reflex response in contused rats after combinational treatment strategy, using body weight 
support treadmill training and PNIPAAm-g-PEG scaffold releasing BDNF/NT-3.    
Methods and Materials 
 Spinal cord injury (contusion) and animal care. All animal protocols were in 
accordance with NIH Guide for the Care and Use of Laboratory Animals and approved 
by Rowan School of Osteopathic Medicine Institutional Animal Care and Use Committee 
(IACUC). The study used a total of 38 adult female Sprague-Dawley rats (225-250 g, 
Harlen, NJ). They were housed 2-3 per cage containing alpha-dry bedding with a 
cardboard tube, on a 12-hour light-dark cycle, and had free access to food and water. The 
38 rats were divided into 5 groups, as shown in Table 3. Groups 2-5 received SCI.  
Animals in these groups were anesthetized with an intraperitoneally (i.p.) injection of 
ketamine cocktail containing a mixture of ketamine (76 mg/kg, Fort Dodge Animal 
Health, Fort Dodge, IA), xylazine (7.6 mg/kg, Ben Venue Laboratories, Bedford, OH), 
and acepromazine maleate (0.6 mg/kg, Boehringer Ingelheim Vetmedica, Inc, St. Joseph, 
MO). Animals were shaved and then cleaned with alcohol and betadine, before T9/T10 
laminectomy was performed to expose the dura. They received a moderate contusion 
injury from an impact device with a 10 gram, 2.0 mm diameter rod that dropped from 25 
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mm on exposed spinal cord. Subcutaneous fat was placed on the exposed dura preventing 
adhesions and 4.0 sutures closed the back muscles. The wound was closed with surgical 
wound clips. Rats were placed on a heating pad until conscious and moving regularly. 
Water bottles in the cages were replaced with long stems, and H2O hydrogels and food 
were placed in the cage in the event that the rats could not reach food/water. After 
surgery, rats were injected subcutaneously with saline (3-5 ml) two times a day and 
Ampicillin (.3 cc, 22.7 mg/ml s.c., b.i.d.) once a day. Saline injections were given 10-12 
hours apart, along with manually expressing the rat’s bladder three times a day for 2 
weeks after date of surgery. This minimized dehydration and urinary tract infection. Rats 
with signs of illness after 2 weeks post-surgery were given Children’s Tylenol (.4 ml, 100 
mg/kg) orally one time a day for 2 weeks or as needed. 
 
Table 3 
Number of animals in each group. 
Group Number Injury/Training Received Number of Animals 
Group 1 Sham N=6 
Group 2 Contused N=8 
Group 3 Contused + BWSTT N=8 
Group 4 Contused + Scaffold + 
Neurotrophins 
N=8 
Group 5 Contused + Scaffold + 
Neurotrophins + BWSTT 
N=8 
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Transplantation. One-week post spinal cord injury Groups 4 and 5 received 
scaffold and neurotrophin transplants. Rats were anesthetized with the ketamine cocktail 
and prepared for surgery similar to the initial contusion surgery. The location of injury 
was identified and re-exposed, and approximately 5 ml of PNIPAAm-g-PEG loaded with 
BDNF (0.5 x 106 /5 µl) and NT-3 (0.5 x 106 /5 µl) was injected with a positive 
displacement pipette at the injury site. Post-operative care stayed the same as with the 
initial contusion injury, 2 weeks of saline, Ampicillin, and bladder expression. 
Behavioral analysis. All rats were tested using the Basso, Beattie and Bresnahan 
(BBB, Basso et al., 1995) scale to measure their hindlimb function in an open field 
locomotion. Rats were video recorded for 4 minutes each in a circular enclosure and then 
scored based on their neurological rating scale, ranging from 0 (complete hindlimb 
paralysis) to 21 (normal hindlimb locomotion). The BBB test was conducted before the 
spinal cord injury (baseline), 2-3 days after surgery, and then each week thereafter until 
week 10 by a trained observer and scored by another blind observer. 
Treadmill training. Figure 52 shows a custom-built treadmill with a load cell 
developed for this study. The load cell was attached to the body weight support (BWS) 
rod and read the actual load that the rat exerted on the rod during locomotion. Individual 
components of the custom treadmill are labeled and explained in Figure 53. Rats were 
secured to the BWS arm via a soft cloth vest and attached using Velcro strips and trained 
at 75% BWS at 7 cm/sec. This was done for rats in Groups 3 and 5 one-week post-injury 
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or transplant. Rats were trained 5 days a week, 1000 steps/day for up to 8 weeks as 
shown in Figure 5.3. 
 
 
Figure 52. Custom treadmill and body weight support (BWS). 
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Figure 53. Custom body weight support (BWS) treadmill with components labeled. A) 
National Instruments myDAQ: paired with LabVIEW VI, the myDAQ issues commands 
to the motor controllers (B and C) and interprets the signal from the load cell amplifier 
(F), B) Treadmill Motor Controller: controls stepper motor used to drive the treadmill, C) 
Spring Tensioning Motor Controller: controls the stepper motor used to tension the 
spring, D) Power Supply: Supplies power to the motors, E) Treadmill Stepper Motor, F) 
Course Adjustment Knob: adjusts the height of the body weight support carriage, G) 
Animal Attachment Plate, H) Load Cell: measures the weight the animal is feeling after 
the spring provides assistance, I) Load Cell Amplification Circuit: amplifies the load cell 
signal before being processed by the my DAQ, J) Tension Spring: provides assistance to 
the animal when weight is supported, K) Spring Tensioning Motor: stepper motor that 
changes the tension of the assistance spring, L) Treadmill Belt, M) Treadmill Base, N) 
Body Weight Support Carriage: carriage attached to the course adjustment which moves 
the spring tensioning system, load cell, and variable angle specimen attachment. 
 
 
 
Figure 54. Rat undergoing BWSTT.  
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Electrophysiology (H-reflex). Eight weeks after contusion or transplant, rats were 
anesthetized with ketamine cocktail, and their right hindlimbs were shaved, and then 
cleaned with alcohol. The right tibial nerve was exposed and lifted using a hook electrode 
(Figure 55), with active needle electrodes inserted between the fourth and fifth 
metatarsal, and the reference/recording electrode inserted in the skin of the fifth digit. 
The nerve was preserved using mineral oil throughout the test. The tibial nerve was 
stimulated using an A-M Systems Isolated Pulse Stimulator Model 2100 where the 
response was amplified with an A-M Systems Differential Amplifier Model 1700. The 
signal was sent to a Tektronix TDS 310 two channel oscilloscope and National 
Instruments USB-6212 BNC, which sent the information to the LabVIEW program 
loaded on the computer as shown in Figure 56. First the nerve was stimulated at .3 Hz to 
determine the threshold and maximum stimulus response levels. Once the threshold was 
found, the H-reflex of the tibial nerve was conducted at .3 Hz and 10 Hz at the particular 
stimulus. A 5-10-minute delay was introduced between the two tests to allow the nerve to 
return to baseline electrophysiological state.   
 
 
Figure 55. Bipolar hook electrode. 
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Figure 56. Set up of A-M Systems Isolated Pulse Stimulator Model 2100, A-M Systems 
Differential Amplifier Model 1700, and Tektronix TDS 310 oscilloscope used for H-
reflex. A) Mineral oil, B) Stimulator, C) Amplifier, D) Oscilloscope.  
 
 
 
A	
B	
C	
D	
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Figure 57. NI USB-6212 used to collect M and H waves. 
 
 
Figure 58. A schematic diagram of how the M and H waves are stimulated and the path it 
travels to the spinal cord to produce the response. 
 
  
Statistical analysis. Statistical analysis was done using repeated measure 
ANOVA for BBB data between groups and time, with time taken as a repeated measure 
beginning at 1 week after training. The Turkey’s test was used for post hoc analysis of 
parametric data, and the Mann-Whitney U test for nonparametric data. H-reflex was 
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analyzed using a one-way ANOVA between groups, followed by Turkey’s post hoc test 
when appropriate. All values are expressed as mean +/- standard error of mean (SEM). 
All statistical analyses were performed using SPSS 11.5 for Windows Software, and 
significance was determined using a p-value of <0.05.  
Results 
Behavior test-overground BBB test. A baseline and weekly BBB scores are 
shown in Figure 59. Functional recovery was observed in BWSTT and combinational 
groups (Groups 3 and 5) but were not statically different from the Sham, Injury, and 
Transplant groups (Groups 1,2 and 4) (Figure 59). 
 
97	
	
 
Figure 59. BBB Scores. 
 
H-reflex. Figure 60 shows H-reflex response waveforms to stimulation at 0.3 and 
10 Hz for all five groups. Figure 60A represents recording from a control animal 
stimulated at 0.3 Hz (the 100% response), along with (Figure 60B) the response at 10 Hz 
(group mean ± SEM, 15.3±3.9% of the response at 0.3 Hz), and the response from an 
injury animal at 0.3 Hz (Figure 60C) (100%) and at 10 Hz (65.7±5.7%) (Figure 60D). 
Figure 60E and 60F show the H-reflex response of a transplant animal at 0.3 Hz (100%) 
and 10 Hz (58.7±8.8%). Figures 60G and 60H show the H-reflex response of a BWSTT 
animal at 0.3 Hz (100%) and 10 Hz (26.7±6.9%). Figures 60I and 60J show the H-reflex 
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response of a combinational animal at 0.3 Hz (100%) and 10 Hz (26.7±6.9%). These 
recordings demonstrate that in control animals, there is frequency-dependent depression, 
and this depression is lost in the injury and transplant groups, but not in the BWSTT and 
combinational groups. 
 Averages of the last 11 M and H responses were calculated for both stimulus 
frequency trains. Figure 61 shows the H/M ratio for each group at 10 Hz. This H/M ratio 
was plotted to determine the H-reflex rate depression seen in each group. Frequency 
dependent depression was observed to be restored in the BWSTT and combinational 
groups and not in the injury and transplant groups. Injury and transplant groups (*) were 
significantly different from control, BWSTT, and combinational groups (+) at the p<0.05 
level. These results suggest that BWSTT and combinational treatment leads to a 
restoration of frequency dependent depression of the H-reflex. ANOVA of these groups 
showed statistically significant differences between experimental groups (df=4, 
F=49.854, P<0.05). Post hoc comparison between all groups showed significance at 10 
Hz between the control, BWSTT, and combinational groups and the injury and transplant 
groups.  
 Figure 62 is a graph of the habituation of the H-reflex following stimulation at 0.3 
and 10 Hz for the following groups of animals: Sham, Injury, Transplant, BWSTT, and 
Combinational. Statistically significant differences between injury and transplant (*) 
groups and the control, BWSTT, and combinational (+) groups were seen at the p<0.05 
level for 10Hz. ANOVA of these groups showed statistically significant difference 
between experiment groups (df=4, F=14.212, p<0.05). Post hoc comparison also showed 
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the same significance at 10 Hz as the H/M ratio plot. The control, BWSTT, and 
combinational groups were significantly different from the injury and transplant groups.  
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Figure 60. Averages of H-reflex recording at 0.3 and 10 Hz. The M-wave amplitude 
remains constant while the H-wave amplitude decreases with increasing stimulus 
frequency. A) H-reflex waveform response to stimulation at 0.3 Hz on a control rat. B) 
H-reflex waveform response to stimulation at 10 Hz in the same control rat. C) H-reflex 
waveform response to stimulation at 0.3 Hz in an injury only rate. D) H-reflex waveform 
response to stimulation at 10 Hz in the same injury only rat. There is a decrease in the 
frequency-dependent depression compared to control. E) H-reflex waveform response to 
stimulation at 0.3 Hz in transplant (scaffold and neurotrophins) animal. F) H-reflex 
waveform response to stimulation at 10 Hz in the same transplant rat. The transplant 
group also has a decrease in the frequency-dependent depression compared to control. G) 
H-reflex waveform response to stimulation at 0.3 Hz in a body weight support treadmill 
training (BWSTT) rat. H) H-reflex waveform response to stimulation at 10 Hz in the 
same BWSTT rat. I) H-reflex response waveform response to stimulation at 0.3 Hz in a 
combinational rat. J) H-reflex response waveform response to stimulation at 10 Hz in the 
same combinational rat. Note that the BWSTT and combinational groups had a return of 
frequency-dependent depression of the H-reflex. Calibration bars vertical 2 mV, 
horizontal 0.02 sec.  
Sham	
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B	 D	
C	
F	
E	
H	
G	
J	
I	
0.02	sec	
101	
	
 
Figure 61.  H ratio – 10/0.3 Hz for each group. The injury and transplant groups (*) are 
significantly different from the sham, BWSTT, and combinational groups (+) at the 
P<0.05 level. *, +: Non-Significant.  
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Figure 62. H/M Ratios at 0.3 and 10 Hz for control (circles), injury (square), BWSTT 
(diamond), transplant (asterisk) and combinational (triangle). Data normalized at 0.3 Hz 
indicates the injury and transplant groups (*) to be significantly different from the 
BWSTT, sham, and combinational groups, P<0.05 level (+). *, +: Non-Significant. 
 
 
Discussion 
The hypothesis for this study is that neurotrophins secreting scaffold will (1) protect 
and minimize the secondary damage that the descending pathways undergo (2) promote 
growth of new pathways and (3) help achieve a better H-reflex response after body 
weight support treadmill training (BWSTT). Part 1 and 2 of the hypothesis will be proven 
later in phase 2: histology, part 3 was proven to be true according to results of part 1 
presented in this paper. 
The behavior analysis (BBB) showed no significance difference between groups. This 
is a course measurement of behavior recovery, that does not look at capturing 
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improvement in weight support and locomotion speed. This is why he second part of the 
study is kinematics analysis which is still ongoing. Kinematic analysis was tested at 75%, 
65%, and 55% body weight support at a speed of 7cm/s and 10cm/s and this will help 
show if there is functional recovery within BWSTT and combinational groups. 
Another thing to point out is why was there improvement of the H-reflex but not in 
the BBB scores (motor function). In motor functions, there are both poly and mono 
synaptic pathways that are involved, whereas the H-reflex is just a monosynaptic 
pathway (Lee et al., 2005; Gozariu et al., 1998). The monosynaptic pathways still give us 
critical information regarding spasticity which we know as a secondary complication 
after SCI (Adams et al., 2005). 
The H-reflex has been a reliable and accurate measure of the changed spinal circuitry 
after spinal cord injury (SCI) in both contusion/compression (Lee et al., 2005; Magnuson 
et al., 1999; Skinner et al., 1996) and transection (Reese et al., 2006; Yates et al., 2008) 
models as well as in humans (Boorman et al., 1992; Phadke et al., 2006; Phadke et al., 
2007; Rayegani et al., 2011; Schindler-Ivens et al., 2000; Yates et al., 2008). The 
contusion/compression models closely resemble the most common human spinal cord 
injuries (Blight et al., 2000; Magnuson et al., 1999), and can be used to assess all stages 
of the injury (spinal cord trauma, secondary tissue destruction, tissue repair process, 
stabilization of chronic lesion, and long-term disability) (Blight et al., 2000). The 
transection model is mainly used to test nerve fiber regeneration and cell transplantation 
(Blight, 2000). In the contusion/compression models, it is possible for the animals to 
regain some motor function, which is commonly observed in humans after SCI (Eaton, 
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2003). Our study used a moderate contusion injury, because we aimed to study the effects 
of bioengineering scaffold releasing neurotrophins and body weight supported treadmill 
training on H-reflex after incomplete injuries.     
After SCI, the spinal circuitry changes and there is a reorganization (Reese et al., 
2006) because of the loss of descending fibers modulating inhibitory fibers. These 
descending fibers are responsible for presynaptic inhibition of IA afferents onto 
motoneurons (Skinner et al., 1996). The H-reflex amplitude has shown to be proportional 
to the number of motoneurons that are activated at any stimulus, and the reflex measures 
the transmission between muscle afferents and the motorneurons (Skinner et al., 1996) 
and is influenced by the supraspinal control (Lee et al., 2005). After injury, the H-reflex 
response is exaggerated greatly (Phadke et al., 2007). The change in H-reflex amplitude 
at different stimulus frequency is the change in the excitability of the reflex pathways 
(Schindler-Ivens et al., 2000).  At a higher frequency in a normal animal, a frequency-
dependent depression is seen in the H-reflex, and after SCI, there is a decrease in the 
depression (Figure 60).  This frequency-dependent depression results from the 
presynaptic inhibition due to lost descending fibers and the lack of changes in the 
motorneuronal excitability, which essentially controls the amplitude of the H-reflex 
(Skinner et al., 1996). Reese et al., 2006 reported that the decreased depression at low 
frequencies is related to a decrease in presynaptic inhibition. This draws our first 
hypothesis that by protecting and minimizing secondary damage of the descending 
pathways, a restoration of the H-reflex can occur.  
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It has been previously studied that the H-reflex is altered with rhythmic motions such 
as stepping, walking, running, and pedaling (Reese et al., 2006). Many studies have 
looked at incorporating an exercise regimen to produce a more normalized H-reflex 
depression because the exercise can compensate for the loss in presynaptic inhibition that 
happens after SCI, because the hindlimb/leg muscles are being alternately stretched in 
some form (Phadke et al., 2007; Skinner et al., 1996).  Our study used a training regimen 
of BWSTT and the results showed that the BWSTT and combinational (Tx and BWSTT) 
groups did present a more normalized frequency rate depression as in the control group, 
when compared to the injury and transplant groups. These results were also reported by 
Skinner et al., 1996, where exercise helped to reorganize and preserve presynaptic 
inhibition producing an H-reflex amplitude with normal levels of frequency-dependent 
depression. In a similar study conducted by Reese et al., 2006, motorized bicycle exercise 
training (MBET) was shown to restore frequency-dependent depression of the H-reflex to 
normal level in the exercise, transected group. Boorman et al., 1992 study showed that H-
reflex changes observed during pedaling and walking were due to presynaptic inhibition. 
It is also important to note that the level at which the spinal cord is transected can affect 
the H-reflex results at high frequencies. Skinner et al., 1996 supports the theory that at the 
T10 thoracic level, there is a reduced depression of the H-reflex at high frequencies. A 
study conducted by Reese et al., 2006 reported differently, in that their T10 transected 
group did not show any frequency-dependent depression at most stimulation frequencies. 
There have also been studies that have looked at how the severity effects the H-reflex. 
One particular study by Lee et al., 2005 showed that the changes that were observed in 
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the H-reflex results may be related to the severity of SCI. Our study used a moderate 
contusion injury across all of the groups. 
Another aspect of SCI that becomes a problem to patients is spasticity. Spasticity can 
be seen in many forms such as hyperreflexia, clonus, clasp-knife responses, long-lasting 
cutaneous reflexes, and muscle spasms (Elbasiouny et al., 2010). One most commonly 
studied component of spasticity is hyperreflexia. The exact reason why hyperreflexia 
occurs is still unknown, but there have been reports of loss/decrease of presynaptic 
inhibition of Ia terminals, increase in postsynaptic receptor excitability, synapse growth 
and changes in intrinsic properties of alpha motorneurons (Reese et al., 2006; Yates et al., 
2008) are involved. In humans, spasticity has been related to specific changes in 
excitability patterns of the soleus H-reflex (Phadke et al., 2007). Studies have shown that 
hyperreflexia is evident in animal models of SCI (Skinner et al., 1996), but does not 
happen immediately after SCI (Schindler-Ivens et al., 2000). It develops within 6-28 days 
after SCI in a contusion animal model (Yates et al., 2008) and has been shown to be 
evident even after 30 days (Reese et al., 2006). Since the hyperreflexia can be due to the 
loss/decrease of presynaptic inhibitions, researchers incorporate an exercise regimen that 
is known to compensate for the loss of presynaptic inhibitions and potentially decrease 
hyperreflexia. In our study, the H/M ratio was plotted for each group to see the 
habituation of the H-reflex. The lack of habituation shows that hyperreflexia may be 
present within those groups. The results showed that the injury and transplant groups 
presented very little habituation and the control, BWSTT, and combinational groups 
showed habituation. These results show that there was a possible increase in presynaptic 
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inhibition in the BWSTT and combinational groups producing a more normalized H-
reflex response.    
 The combinational group used in our study has a combination of BWSTT and the 
bioengineered scaffold PNIPAAm-PEG loaded with neurotrophins (BDNF/NT-3). 
Biomaterials scaffolds, in general, are used to help bridge the gap between the lost tissue. 
They provide a site for an implant or host cells, and are capable of releasing therapeutic 
agents within the injured spinal cord, such as neurotrophins.  These scaffolds also have 
the capability to preserve the local environment of the spinal cord through decreasing 
apoptosis of cells, inflammation and scar formation. The biomaterials are constructed 
from synthetic polymers that are easily blended together to create a unique biomaterial 
with the mechanical and physiochemical properties needed for its application (Kim et al., 
2014). Some of PNIPAAm unique properties, which make it suitable for implantation 
within the spinal cord, are that is has compression modulus values in the range from 0.7 
to 600 kPa and the self-ability to show thermal transitioning (Alexander et al., 2014). 
PEG also has a unique property that allows it to have an immune protecting effect on the 
spinal cord defects, because it helps to reseal cell membranes, which limits apoptosis 
(Assuncão-Silva et al., 2014; Kim et al., 2014). Also, when implanted into the spinal 
cord, the PEG polymer is very resistant to recognition by the immune system not 
producing a response from the body (Assuncão-Silva et al., 2014). This unique 
combination of PNIPAAm-PEG has been previously studied in spinal cords for cell 
transplantation, such as bioactive neurotrophins (Comolli et al., 2009; Grous et al., 2013; 
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Piantino et al., 2006) and load-bearing soft tissue applications (Alexander et al., 2014; 
Thomas et al., 2010).  
These reported studies all used some form of the hydrogel PNIPAAm-PEG, 
except for Piantino et al., 2006. Piantino et al., 2006 looked at how PEG alone, coupled 
with NT-3, would improve recovery in a T8 laminectomy. The study reported improved 
locomotor recovery and greater axon growth when compared to control. Another study 
conducted by Grous et al., 2013 performed a cervical dorsolateral funiculotomy, and 
results showed that the cross-linked hydrogel PNIPAAm-g-PEG allowed axonal growth 
and successfully delivered BDNF into the injured spinal cord, while increasing recovery 
rate of fine motor function, when compared to control group (PNIPAAM-g-PEG only).  
Comolli et al., 2009 performed a similar study to Grous et al., 2013, but looked further 
into the neurotrophins and material properties of the neuronal tissue. The results showed 
that using PNIPAAM-PEG, loaded with NT-3 and BDNF neurotrophins were sustained 
for up to 4 weeks within the injury site, and bioactivity was confirmed after 4 weeks. 
Overall results from this study showed that PNIPAAm-PEG scaffold can be modified to 
match the mechanical properties of the neuronal tissue present within the spinal cord. 
Previous studies like Comolli et al., 2009 showed that PNIPAA-PEG it is capable of 
releasing a drug over a long period of time and is biocompatible and biodegradable.  
The growth factors NT-3 and BDNF are neurotrophins found in peripheral nerves 
and the spinal cord. They have shown to affect circuit behavior within the spinal cord. 
Long term treatment with these neurotrophins can provide a detour around the injury site 
of the spinal cord in neonatal and adult rats.  Specifically looking at NT-3, it helps in the 
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survival of sensory afferent and it strengthens the group Ia synaptic projection to 
motorneurons. BDNF does not have an effect of the strength of the synaptic projections 
like NT-3, but it enhanced motor neuron excitability, which will produce a better H-
reflex amplitude. It can also reduce synaptic inhibition (Boyce et al., 2014). 
Conclusion 
 This study strengthens the results of previous studies in finding that an exercise 
regimen can help restore the frequency-dependent depression of the H-reflex (Lee et al., 
2005; Reese et al., 2006; Skinner et al., 1996; Yates et al., 2008). Our study showed this 
restoration was present in the BWSTT and combinational groups, but not in the transplant 
group. The same effect was seen with the BBB test, such that the BWSTT and 
combinational groups exhibited functional recovery, but not the transplant group when 
compared to sham. There was also a decrease in habituation of the H-reflex, seen in both 
the BWSTT and combinational groups. These results open a new gateway for incomplete 
SCI patients through a unique tissue-engineering approach that has shown promise in 
clinical application. Our unique tissue engineering approach of using PNIPAA-m-PEG 
loaded with BDNF/NT-3 improved the H-reflex response in all aspects from habituation, 
spasticity, and frequency-dependent depression, but not as well as the BWSTT group. 
Future studies can combine this PNIPAA-m-PEG scaffold with other growth promoting 
agents, as well as different exercise regiments to explore the beneficial effects of the 
proposed combination treatment strategy in incomplete SCI animal models to see if a 
unique combination is proven more beneficial than BWSTT alone. This unique tissue-
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engineering approach did not show a better result when compared to the BWSTT group, 
but did show promise when compared to sham and injury group. 
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Chapter 6 
Future Work 
There is much more future work that has to be done in order to cure spinal cord injuries. 
The study posed some limitations with respect to the bioengineered scaffold and 
rehabilitation techniques. Future work is needed to improve the study and the outcomes. 
Future studies should first look at the PNIPAAm-g-PEG with neurotrophins scaffold to 
access the changes in the anatomical and synaptic plasticity. These changes will access 
the neuroprotective and neroregenerative properties and to see if the scaffold was 
successful in establishing anatomical connections, while preserving spared descending 
pathways. If the PNIPAAm-g-PEG scaffold was found to be successful, then more 
studies should be conducted with that scaffold to improve the procedure and outcome of 
the studies. The scaffold injection process should be tested to access the amount of 
scaffold that was actually injected into the injury site. Problems arise with the scaffold 
leaking during injection. There needs to be a set procedure that can quantify and ensure 
the same amount of scaffold is injected into the injury site each time. Taking this into 
consideration can allow for better results and will eliminate the outliers that may have 
received more or less of the scaffold. 
 Future studies should also look at using different exercise regiments, such as 
robotic treadmill training because it is more accurate and precise during training (Querry 
et al., 2008). In our study this can be the reason why the BWSTT and combinational 
groups showed no difference statically. Another exercise regimen that can be tested with 
our bioengineered scaffold is motorized bicycle exercise. Skinner et al., 1996 and Reese 
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et al., 2006 studies showed that it was capable of restoring the H-reflex, so I would test 
for difference in the training and combinational groups because we did not see it in our 
study.  
Studies should also look at different bioengineered scaffolds that have already 
proven helpful in some form for spinal cord injury repair. They should be tested to access 
their neuroprotective and neuroregeneration properties.  Once these scaffolds are 
identified to have neuroprotective and neuroregeneration properties, they should be tested 
with different growth factors. Our transplant group using PNIPAAm-PEG loaded with 
BDNF/NT-3 did not show restoration of the H-reflex so a future study can look at 
replacing BDNF with NGF. NGF is known to prevent degeneration of neurons (Nerve) 
instead of encouraging neurogenesis (birth of neurons) like BDNF does (Patrick et al., 
2011). Also combining NGF with NT-3 will allow different population to be affected by 
the neurotrophins (Nerve). 
 Another direction that future work can take is to study combinational 
biomaterials. These combinational biomaterials combine both cell-based therapies with 
hydrogel-based biomaterials. Since each part separately has shown to have some form of 
neuroprotective and neuroregenerative properties, they can be combined in a unique way 
to enhance these properties and to provide repair for spinal cord injury. There are many 
combinations that are able to be tested, but some may pose more ethical issues than 
others. This is the balance that researchers and society have to work with, but once there 
is a balance, combinational biomaterials have the best chance in spinal cord injury repair.  
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Appendix 
 Definitions 
Adipocyte – Fat cell 
Afferent – Bearing or conducting inward; specifically: conveying impulses toward the 
central nervous system 
Aliphatic – Of, relating to, or being an organic compound (as an alkane or alkene) 
having an open-chain structure 
Angiogenesis – The formation and differentiation of blood vessels 
Anterior – Relating to or situated near or toward the head or toward the part in headless 
animals most nearly corresponding to the head; situated toward the front of the 
body 
Antidromic – Proceeding or conducting in a direction opposite to the usual one – used 
especially of a nerve impulse or fiber 
Apoptosis – A genetically directed process of cell self-destruction that is marked by the 
fragmentation of nuclear DNA and is a normal physiological process eliminating 
DNA-damages, superfluous, or unwanted cells – called also programmed cell 
death 
Arachnoid – A thin membrane of the brains and spinal cord that lies between the dura 
mater and the pia mater 
Astrocytes – A star shaped cell; especially: and comparatively large much-branched  
       neuroglial cell 
Axon – A usually long and single nerve-cell process that usually conducts impulses away 
from the cell body 
Bioengineered - The application of biological techniques (as genetic recombination) to 
create modified versions of organisms 
Blood-Brain Barrier – A barrier created by the modification of brain capillaries (as by 
reduction in fenestration and formation of tight cell-to-cell contacts) that prevents 
many substances from leaving the blood and crossing the capillary walls into the 
brain tissue 
Cardiac Output – The volume of blood ejected from the left side of the heart in one 
minute 
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Cerebrospinal Fluid - A liquid that is comparable to serum but contains less dissolved 
material, that is secreted from the blood into the lateral ventricles of the brain, and 
that serves chiefly to maintain uniform pressure within the brain and spinal cord 
Chondrocyte – A cartilage cell 
Clonus – A series of alternating contractions and partial relaxations of a muscle that in 
some nervous diseases occurs in the form of convulsive spasms 
Dendrite – Any of the usually branching protoplasmic process that conducts impulses 
toward the body of a nerve cell 
Distal – Situated away from the part of attachment or origin or a central point as a: 
located away from the center of the body b: located away from the mesial plane of 
the body 
Dorsal – Being or located near, on, or toward the upper surface of an animal (as a 
quadruped) opposite the lower or ventral surface; being or located near, on, or 
toward the back or posterior part of the human body 
Dura Mater – The tough fibrous membrane lines with endothelium on the inner surface 
that envelopes that brain and spinal cord external to the arachnoid and pia mater 
that in the spinal cord is separated from the bone by a considerable space and 
contains no venous sinuses 
Efferent – Conducting outward from a part or organ specifically: conveying nervous 
impulses to an effector 
Endoneurial – Endonerurium – The delicate connective tissue network holding 
together the individual fibers of a nerve 
Endoneurium – The delicate connective tissue network holding together the individual 
fibers of nerve trunk 
Epineurium – The external connective tissue sheath of a nerve trunk 
Extension – The stretching of a fractured or dislocated limb so as to restore it to its 
natural position: an unbending movement around a joint in a limb (as the knee or 
elbow) that increases the angle between the bones of the limb at the joint 
Extracellular – Situated or occurring outside a cell or the cells of the body 
Fibrocartilage – Cartilage in which the matrix, except immediately about the cells, is 
largely composed of fibers like those of ordinary connective tissue; also: a 
structure or part composed of such cartilage 
Flexion – A bending movement around a joint in a limb (as the knee or elbow) that 
decreases the angle between the bones of the limb at the joint 
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Glial – Glia – Supporting tissue that intermingles with the essential elements of nervous 
tissue especially in the brain, spinal cord, and ganglia and is composed of a 
network of fine fibrils and of flattened stellate cells with numerous radiating 
fibrillary processes 
Habituation – A form of non-associative learning characterized by a decrease in 
responsiveness upon repeated exposure to a stimulus 
Hemorrhaging – A copious discharge of blood from the blood vessels 
Hydrogel – A gel in which the liquid is water 
Hydrophilic – of, relating to, or having a strong affinity for water 
Hyper-excitability – The state or condition of being unusually or excessively excitable 
Hyperextension – To extend so that the angle between bones of a joint is greater than 
normal; also: to extend (as a body part) beyond the normal range of motion 
Hyperreflexia – Over activity of physiological reflexes 
Inflammation – A local response to cellular injury that is marked by capillary dilatation, 
leukocyte infiltration, redness, heat, pain, swelling, and often loss of function and 
that serves as a mechanism initiating the elimination of noxious agents of 
damaged tissue 
Intramedullary – Situated or occurring within a medulla; especially: involving use of 
the marrow space of a bone support 
Kyphosis - Exaggerated backward curvature of the thoracic region of the spinal column 
Laminae – A thin plate or layer especially of an anatomical part 
Laminectomy – Surgical removal of the posterior arch of a vertebra 
Lateral – Of or relating to the side; especially, of a body part: lying at or extending 
toward the right or left side: lying away from the median axis of the body 
Leukocyte – White blood cell, a cell (as a macrophage) of the tissues comparable to or 
derived from a leukocyte 
Lordosis – Exaggerated forward curvature of the lumbar and cervical regions of the 
 spinal column 
Lymphocyte – Any of the colorless weakly motile cells originating from stem cells and 
differentiating in lymphoid tissue (as of the thymus or bone marrow) that are the 
typical cellular elements of lymph, include the cellular mediators of immunity, 
and constitute 20 to 30 percent of the white blood cells of normal human blood 
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Macrophage – A phagocytic tissue cell of the immune system that may be fixed or freely 
motile, is derived from a monocyte, functions in the destruction of foreign 
antigens, and serves as an antigen-presenting cell 
Matrix – The extracellular substance in which tissue cells (as of connective tissue) are 
embedded 
Medial Malleolus – A strong pyramid shaped process of the tibia that projects distally on 
the medial side of its lower extremity at the ankle 
Median – Situated in the middle; specifically: lying in a plane dividing a bilateral animal 
into right and left halves 
Metatarsal – Of, relating to, or being the part of the human foot or of the hind foot in 
quadrupeds between the tarsus and the phalanges that in humans comprises five 
elongated bones, which form the front of the instep and ball of the foot 
Mixed Nerve – A nerve containing both sensory and motor fibers 
Monocyte – A large white blood cell with finely granulated chromatin dispersed 
throughout the nucleus that is formed in the bone marrow, enters the blood, and 
migrates into the connective tissue where it is differentiated into a macrophage 
Monomer – A chemical compound that can undergo polymerization 
Monosynaptic – Having or involving a single neural synapse 
Motor – Of or relating to, or being a motor neuron or a nerve containing motor neurons; 
of, relating to, concerned with, or involving muscular movement 
Multipolar – Having several dendrites 
Myelinated – Having a myelin sheath 
Myelination – The process of acquiring a myelin sheath; the condition of being 
myelinated 
Nerve Fiber – Any of the processes (as an axon or a dendrite) of a neuron 
Neuroglia – glia: Supporting tissue that is intermingled with the essential elements of 
nervous tissue, especially in the brain, spinal cord, and ganglia and is composed 
of a network of fine fibrils and of flattened stellate cells with numerous radiating 
fibrillar processes 
Neurolemma – Neurilemma : The outer layer surrounding a Schwann cell of a      
                                        myelinated axon 
Neuron – One of the cells that constitute nervous tissue, that have the property of 
transmitting and receiving nervous impulses, and that possess cytoplasmic 
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processes which are highly differentiated frequently as multiple dendrites or 
usually as solitary axons, and which conduct impulses toward and away from the 
cell body 
Neuroprotective - Serving to protect neurons from injury or degeneration 
Neurotransmitter – A substance that transmits nerve impulses across a synapse 
Neurotrophin – Neurotrophic factor: Any of a group of neuropeptides (as nerve growth 
factor) that regulate the growth, differentiation, and survival of certain neurons in 
the peripheral and central nervous system 
Neutrophil – A granulocyte that is the chief phagocyte white blood cell 
Olfactory Bulb – A bulbous anterior projection of the olfactory lobe that is the place of 
termination of the olfactory nerves 
Olfactory Nerve – Either of the pair of nerves that are the first cranial nerves, that serve 
to conduct sensory stimuli from the olfactory organ to the brain, and that arise 
from the olfactory cells and terminate in the olfactory bulb 
Oligodendrocyte – A glial cell resembling an astrocyte, but smaller with few and slender 
processes having few branches and forming the myelin sheath around axons in the 
central nervous system 
Orthodromic – Proceeding or conducting in a normal direction – used especially of a 
nerve impulse or fiber 
Osteoblast – Bone forming cell 
Paralysis – Complete or partial loss of function especially when involving the power of 
motion or of sensation in any part of the body 
Perineurium –The sheath of connective tissue that surrounds a bundle of nerve fibers 
Phagocyte – A cell (as a macrophage or neutrophil) that engulfs and consumes foreign 
material (as microorganisms) and debris (as dead tissue cell) 
Pia Mater – The delicate and highly vascular membrane of connective tissue investing 
the brain and spinal cord, lying internal at the arachnoid and dura mater, dipping 
down between the convolutions of the brain, and sending an ingrowth into the 
anterior fissure of the spinal cord 
Pluripotent – Not foxes as to developmental potentialities; especially: capable of 
differentiating into one of many cell types 
Polymer – A chemical compound or mixture of compounds formed by polymerization 
and consisting essentially of repeating units 
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Posterior –Situated behind: as a: situated at or toward the hind part of the body: caudal b: 
dorsal – used of human anatomy in which the upright posture makes dorsal and 
caudal identical 
Process – A part of the mass of an organism or organic structure that projects outward 
from the main mass 
Soleus – A broad, flat muscle of the calf of the leg that lies deep to the gastrocnemius, 
arises from the back and upper part of the tibia and fibula and from a tendinous 
arch between them, inserts by a tendon that unites with that of the gastrocnemius 
to form the Achilles tendon, and acts to reflex the foot 
Stroke Volume – The volume of blood pumped from a ventricle of the heart in one beat 
Synapse – The place at which a nervous impulse passes from one neuron to another 
Tibial Nerve – The large nerve in the back of the leg that is a continuation of the sciatic 
nerve and terminates at the medial malleolus in the lateral and medial plantar 
nerves 
Pease, R. W. (2006). Merriam-Webster's medical dictionary. Springfield, MA: Merriam-
Webster. 
 
 
 
 
 
 
 
 
 
 
 
 
 
